americas hepato–pancreato–biliary association - AHPBA...12th Aul eetig 1 AHPBA 2012...

americas hepato–pancreato–biliary association

Eden Roc RenaissanceMiami Beach, FloridaMarch 7–11, 2012

112th Annual Meeting

AHPBA 2012President’s Welcome letter

Welcome to the 12th Annual Congress of the Americas Hepato-Pancreato-Biliary Association (AHPBA), at the Eden Roc Miami Beach! Over these past years, our association has seen tremendous growth in stature and has become a premium forum for academic exchange and collegial interaction. The 2012 meeting, the theme of which is “Impacting Your HPB Practice,” will take us to new heights.

This year’s meeting starts on Wednesday, one day earlier than previous meetings, with an Ultrasound and Advanced HPB Technology course. The course will be followed by an Allied Healthcare Symposium, which features the increasing role of mid-level providers in our HPB practice. On Thursday,

Bill Jarnagin, our President-Elect, has organized an outstanding postgraduate course that will include presentations of HPB cases. This course promises to inspire lively discussions on variations in approaches from world-renowned HPB leaders. On Thursday evening, we will have another new feature: the fellows and residents symposium. Rohan Jeyarajah has gathered experienced and junior faculty in the field of HPB practice who will discuss HPB training and career models in private and academic settings.

The program from Friday to Sunday is an exciting mosaic of parallel symposia, parallel lectures, debates, and scientific presentations. The Presidential Address on Friday morning, “From Couinaud to Molecular Biology: The Seven Virtues of HPB Surgery,” will consider how our practice today was made possible by the achievements of those preceding us. I also encourage you to attend the two lectures on Friday afternoon. David Nagorney is the invited presidential lecturer and will present the experience of a lifetime in his talk, “Hepatic Surgery: Past, Present, and Future.” The second lecturer will be Michael Henderson, who will give the first AHPBA historical lecture, “Treatment of Portal Hypertension.”

The program concentrates on practical knowledge and includes a record number of new faculty and new events. Chuck Vollmer should be congratulated for his tremendous personal engagement with the Scientific Program Committee in crafting a meeting of high quality in depth and content. I also extend my personal thanks to the members of the Development Committee, who participated in writing the proposals for continuing medical education grants and recruiting sponsors for the meeting. Also, please visit our exhibit hall throughout the meeting to learn about our sponsors and personally thank them for participating and supporting us. Finally, Kim O’Dell, Executive Director, and Crow-Segal Management deserve enormous recognition. I thank them for their professionalism, their attention to detail, and their tenacity in managing every aspect of the organization and this meeting. We are very fortunate to have them working with us.

The breadth of this Annual Congress is a testimony to the tremendous growth of our association. Our association has made great strides in the less than two decades of our existence. Our past leaders should be thanked for having worked so hard for the development of our association. Likewise, my deep gratitude goes to all the members of the Executive Council who, during the past year, have contributed to every aspect of the development of the association. Our members remain engaged and active in their participation in the meeting. This year’s program represents the Americas’ best in HPB, and will no doubt inspire more members to engage actively in the life of our association.

It was my pleasure to lead the association this year. Enjoy the meeting, Miami Beach, and interacting with friends and colleagues. Thank you for your hard work and support.

Jean-Nicolas Vauthey, MD AHPBA President

2 Impacting Your HPB Practice�

Thank you Brazilian College of SurgeonS

for your SupporT

2012 sPonsorsThe AHPBA wishes to thank the following organizations for their support of the 2012 Annual Meeting.

educational Grant Provided by

Former ly Sa l ient Surg ica l Technolog ies

Platinum level

Gold level

silver level

bronze level

General meetinG suPPort


AHPBA 2012

aHPba executive council officerspresident: Jean-Nicolas Vauthey, MDpresident-elect: William R. Jarnagin, MDSecretary: William C. Chapman, MDTreasurer: Elijah Dixon, MD

members at larGeJeffrey Barkun, MDCarlos Chan, MDMichael A. Choti MD, MBABryan M. Clary, MD Sean P. Cleary, MDFelipe Jose Fernandez Coimbra, MDMichael D’Angelica, MDXabier Ander de Aretxabala, MDMichael B. Farnell, MDPaul D. Greig, MDJavier Lendoire, MD PhDSusan L. Orloff, MD

Past Presidentsimmediate past president: Reid B. Adams, MDpast president: W. Scott Helton, MD

committee cHairsCeTaT David Iannitti, MD FACS

DevelopmentHoracio Asbun, MD

education & TrainingRebecca Minter, MD

finance Elijah Dixon, MD

hpB program Directors D. Rohan Jeyarajah, MD FACS

international relations Gazi B. Zibari, MD

MembershipTimothy M. Pawlik, MD, MPH, FACS

professional DevelopmentRobert C.G.Martin, II, MD

programCharles M. Vollmer, MD

publicationsCraig Fischer, MD

research CommitteeRoderich E. Schwarz, MD

ex-officio foundation president: W. Scott Helton, MD

aHPba Past PresidentsReid B. Adams, MD 2010 - 2011 W. Scott Helton, MD 2009 - 2010 Mark P. Callery, MD 2008 - 2009 Bruce D. Schirmer, MD 2007 - 2008 Sean J. Mulvihill, MD 2006 - 2007 Theodore Pappas, MD 2005 - 2006

C. Wright Pinson, MD, MBA 2003 - 2005 Steven M. Strasberg, MD 2001 - 2003 Henry A. Pitt, MD 1999 - 2001 William C. Meyers, MD 1997 - 1999 J. Michael Henderson, MD 1995 - 1997

aHPba leadersHiP


aHPba officeexecutive Director: Kim O’Dell, CMP - [email protected]/Database: Mindy Hoo - [email protected]/Sponsorship/advertising: Ralph Robinson, CMP - [email protected]: Debbie Batchelor - [email protected] Support: Rona Long - [email protected]

staff committee liaisons publications, research and international relations: Lyn Henderson, CMPDevelopment, professional Development & CeTaT: Ralph Robinson, CMPeducation & Training, hpB program Directors, finance, program: Kim O’Dell, CMPprogram and Membership: Mindy Hoo

2012 ProGram committee

Charles M. Vollmer, MD2012 Program Chair

Charles M. Vollmer, MD - ChairTodd W. Bauer, MD - Vice/Co-ChairChad G. Ball, MDStephen W. Behrman, MD, FACSCarlos Chan, Sr., MDYun Shin Chun, MDThomas E. Clancy, MDM. B. Majella Doyle, MDRobert E. Glasgow, MDAndrew A. Gumbs, MDWilliam G. Hawkins, MDNicolas P. Jarufe Cassis, MDEugene Paul Kennedy, MDAlan J. Koffron, MDSean Kumer, MD, PhDKristin Leigh Mekeel, MDSatish N. Nadig MD, PhDAttila Nakeeb, MDPurvi Parikh, MDNorberto J. Sanchez, MDThomas Schnelldorfer MD, FACSCharles R. Scoggins, MDMargo C. Shoup, MDKevin F. Staveley-O’Carroll, MD, PhDAllan Tsung, MDBrendan C. Visser, MDTheodore H. Welling, III, MDEmly R. Winslow, MDNicholas J. Zyromski, MD


AHPBA 2012

as of February 1, 2012

aHPba foundation donorsWe are proud to recognize our donors and would like to thank all of the Organizations and Individual Supporters whose continued generosity allows us to promote the research on diseases of the liver, pancreas and biliary tract.

DIAMONDAHPBA

GOlDReid AdamsMark Callery

William ChapmanSean Cleary

Michael D’AngelicaElijah Dixon

O James Garden

Paul GreigWilliam HeltonDavid Iannitti

William JarnaginKeith LillemoeRebecca MinterMichele Molinari

Sean MulvihillSusan Orloff

C. Wright PinsonBruce Schirmer

Jean-Nicolas VautheyGazi Zibari

SIlverDaniel Kleiner

Henry Pitt Roderich SchwarzCharles Vollmer

BrONzeJeffrey BarkunPurvi Parikh

Ponnandia SomasundarKevin Watkins

CONtrIButOrSYun Shin ChunBryan Clary

Douglas Evans Riad Haddad D. Ryan Hall

Paulo Herman

Javier LendoireMariano MoroMayank Roy Margo Shoup

Atsushi Sugioka Rebekah White


2012 distinGuisHed service aWardThe AHPBA Executive Council has voted as the winner of its 2012 Distinguished Service Award, Dr. Paul D. Greig. Dr Greig is Professor of Surgery at the University of Toronto, where his academic and clinical focus is in Transplantation and HPB Surgery. He is the Former Chair of the AHPBA Education & Training Committee and was the AHPBA representative to the Board of the Fellowship Council. He also represented the AHPBA on the Fellowship Council Curriculum Committee.

These offices are only the tip of the iceberg for Dr. Greig, who has also served as President of the Canadian Society of Transplantation and developed the Canadian Standards for the Safety of Perfusable Organ Transplantation,

and he was the Medical Director for the organ procurement Program in Toronto. He has been the Program Director of both the HPB and Transplant Fellowships at the University of Toronto since 1995. He has made a career of bringing together surgeons and organizations into cooperative units and working to create high training standards across specialties. He joined the AHPBA in 2002 at the request of then-President Steven Strasburg, and in 2005 was asked by then-President Wright Pinson to serve as AHPBA’s representative to the Fellowship Council. “I remember distinctly when Dr. Pinson asked me in his elegant Southern drawl to serve as an ad hoc member of the Council. I just couldn’t say ‘no,’” Dr. Greig said.

“I think we have a very good relationship with the Fellowship Council,” he said. “We have approximately 15 HPB fellowships now, up from 8 or 9 before, out of 120 MIS fellowships, yet we have enjoyed the same influence as bigger specialties. We have been influential beyond our size. For example, when the Council created the Curriculum Committee, the template that we developed for the HPB Curriculum became the model for the Curricula for the other Fellowships in Advanced GI Surgery.”

Dr. Greig was instrumental in facilitating an integrated match of the HPB Fellowships with the Fellowships in Surgical Oncology to advantage the Residents applying to our specialty. He was able to receive approval from the Fellowship Council, who agreed even though technically it was contrary to the constitution - as it was clearly in the best interests of the Residents. Since then, the influence of the AHPBA in the Fellowship Council has been enhanced by the former President, Dr. Bruce Schirmer becoming President of the Fellowship Council, and Dr. Rebecca Minter becoming Chair of the Accreditation Committee of the Council.

One of his signature achievements has been the creation of the Fellowship and Training Committee of AHPBA. It started as an ad hoc committee to the Executive Council, and became a standing committee after two years. Now, along with the closely allied Program Directors Committee, it is one of our Association’s most active and important committees.

“Our Society started out as a group of like-minded surgeons who wanted to exchange scientific information and creative ideas,” Dr. Greig said. “Over time, we realized that we had the obligation to set the standards for training in advanced HPB Surgery. It was a natural evolution for the AHPBA to take on the education of its subspecialists. Through the Training & Education Committee, we have worked to establish standards for training in HPB Surgery that are as rigorous as those of our Residency Programs in General Surgery.

Dr. Paul D. Greig


AHPBA 2012

“As much as the AHPBA has advanced in the recent years on many fronts, from the website, to the HPB Journal to our international efforts, one of our greatest contribution may be in this effort to promote and to establish strict, rigorous standards for training in HPB Surgery,” said. “The future of our discipline is dependent on the quality of our next generation of HPB Surgeons. Our efforts have forced the individual Program Directors to do a lot of work, but through visiting each others’ institutions and building an infrastructure of communication and cooperation, the effort is paying great dividends.”

Dr. Greig is also passionate about the AHPBA’s value as a professional organization. “Academic Surgeons are confronted with huge competition for their time in attending professional meetings,” he said. “We have to be quite selective. Yet the AHPBA is my favorite meeting each year. AHPBA brings together a good-sized group in one small hotel. We have no more than two or three concurrent meetings, not like some of the huge congresses with 15 meetings simultaneously. We gain as much from the discussion in the hallways as in the lecture halls. It’s a non-pretentious meeting, very comfortable, with tremendous camaraderie. Plus, each year I get to see about 30 former Fellows from the University of Toronto. It’s always gratifying to catch up with them and introduce them to each other.”

“I am extremely grateful to have received the Distinguished Service Award for 2012,” Dr. Greig concluded. “I am humbled to join the previous winners of this award, who have set high standards and made enormous contributions to our organization and academic discipline.”


aHPba aWards tHree travelinG felloWsHiP aWards!

CongraTulaTionS To The following reCipienTS!

alessandro landskron diniz, md AC Camargo Cancer Hospital, Sao Paulo, Brazil

“I was honored to know a world class HPB surgical department under the supervision of Professor Nick Vauthey. I had the opportunity to understand how to put together a multidisciplinary team on HPB malignancies, discuss numerous cases of colorectal liver metastasis and HCC, as well as learn how clinical research is developed”

micHele molinari, md

Dalhousie University, University Halifax Nova Scotia, Canada

Dr. Molinari travelled to meet with Dr. de Santibañes and Dr. McCormack in Buenos Aires.He learned first hand about creating a large database to study MELD predictive value in the population served by the two transplant centers.

luis carlos cHan nunez, md

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran del Coyoacán, Mexico City, Mexico

“I went to Boston to visit Harvard and its affiliated hospitals mainly Beth Israel Deaconess Medical Center and Massachusetts General.

I learned a lot mainly in the field of pancreatic surgery as an observer. I had the opportunity to see great surgeons in this field and discuss cases. I got involved in clinical activities as making rounds, sessions etc.

It was a great honor for me to be selected for this Traveling Fellowship and I really thank the AHPBA for this opportunity.


AHPBA 2012

micHele babicky From the Laboratory of Andy Lowy, University of California San Diego

TargeTing The ron TyroSine kinaSe reCepTor in panCreaTiC CanCer

research Synopsis: Our laboratory focuses on the role of the RON Receptor Tyrosine Kinase in pancreatic carcinogenesis. We have previously demonstrated that RON overexpression confers apoptotic resistance in pancreatic cancer, and that down-regulation of this receptor can sensitize cancer cells to gemcitabine treatment. In this project, I will be evaluating the effect of a novel RON inhibitor on tumor growth using a patient-derived orthotopic xenograft model. The inhibitor, RON-8, is a human monoclonal antibody directed against the RON receptor that is currently in Phase I clinical trials. We will compare the efficacy of this agent, both alone and in combination with gemcitabine.

We will screen patient derived xenografts for sensitivity to RON-directed therapy, and then use these tissues to identify potential biomarkers that may predict a response to anti-RON therapy. We have previously studied the transcriptome in pancreatic cancer cells exposed to RON ligand, as well as in tumor xenografts from RON-expressing and RON-silenced cells. These data implicated two genes (IL-11 and Bcl-6) whose transcripts were differentially expressed. We hypothesize that IL-11 and Bcl-6 may serve as biomarkers of activated RON signaling in pancreatic cancer. We will use the tissues from these experiments to test this hypothesis, as well as to derive a genomic signature that may predict response to RON-8.

Accomplishing these aims will significantly narrow the gap in our understanding of how RON signaling contributes to pancreatic cancer progression and how RON-directed therapies can be most successfully designed and utilized in pancreatic cancer patients.

2011 aHPba researcH aWard uPdate


2012 aHPba foundation

Stop by the Foundation Table in the registration area and purchase a drawing ticket or make a bid on a great Auction item!

Tickets may be purchased - 1 for $20 or 4 for $50 for the drawings. You may then place your ticket(s) into the specific drawing box for a chance to win the following:

prizes include:•2012 IHPBA World Congress Meeting Registration•2013 AHPBA Annual Meeting Registration, including two night’s accommodations•2013 AHPBA / Mexico Joint Meeting Registration, including two night’s accommodations•$500 in Cash

auction item:One-week getaway in Costa Rica at a Private Villa! This is an incredible destination and value! Bidding begins at $3,000.

2012 cme certificates & conference evaluations

All attendees will receive their CME and Attendance Certificates by completing the evaluations online. You will receive an email (using the email that you registered with for the conference and listed on your registration envelope) explaining how to complete your evaluation. If you have not received this email by the end of the meeting, please let someone at the AHPBA Registration Desk know. You will not need to contact anyone to send you your certificate, as you will be able to print your own as soon as you complete your online evaluation. However, should you experience any problems with the evaluation either during or after the Congress, please contact Rona Long – [email protected] or 407-647-8839. She will be glad to assist you.

Onsite registrants: Your email will come at a later date.

meetinG videos available for PurcHase

MEDCALDTV will be on-site video taping the meeting. If you would like to order a copy, you may do so onsite or take an order form with you.

2012 HPb certificates of comPletion to be aWarded

Congratulations to the following members who have successfully completed their fellowship training and have fulfilled the surgical curriculum requirements, as set forth by the AHPBA and Fellowship Council.

These individuals will be recognized on Friday morning, March 9, at the beginning of the President’s Plenary session.

Adnan Alseidi, MDDaniel Cusati, MDTruman Markley Earl, MDAdrian Fox, MDFarhaad Golkar, MDChet Hammill, MDSrinivas Kavuturu, MDRebecca L. Keim, MDKevin M. Lowe, MD


AHPBA 2012a Gentle reminderEvery precaution to assure the safety and security of our attendees and their guests has been taken. However, we urge you to be aware and take simple steps to guard your possessions. •Donotleaveyourpurseofbriefcaseunattended •Donotleaveyourlaptop,phoneorPDA’sonthefloororoutofyoursight •Beawareofyoursurroundings

If you do misplace or lose something, please let someone at the Registration Desk know immediately.

neW!…simultaneous interPretation from enGlisH to sPanisHThis service will be available in the main meeting room throughout the meeting. If you are interested in receiving a headset, please check in at the AV table in the back of Ocean Tower I A-C

audience resPonseThis interactive feature will be incorporated into several symposia at the meeting. Handsets will be distributed throughout the meeting rooms.

Have a Safe and Secure Meeting.

maintenance of certificationMaintenance of Certification offered for attending Thursday’s Postgraduate course. The post test will be available online after the course.

exHibit HallHoursThursday, March 8 5:30 - 7:00 pm

Friday, March 9 12:00 - 7:15 pm

Saturday, March 10 7:00 am – 12:00 pm

Poster session HoursFriday, March 9 5:00 – 6:30 pm

Saturday, March 10 5:30- 7:00 pm

scHeduled events in tHe exHibit Hall:ThurSDay, MarCh 85:30 - 7:00 pm Welcome Reception

friDay, MarCh 912:30 - 1:30 pm Lunch in the Exhibit Hall

6:45 - 7:30 pm Cocktail Reception

SaTurDay, MarCh 10

7:00 - 8:00 am Breakfast with the Exhibitors


cme accreditation statementThis activity has been planned and implemented in accordance with the essential areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of CMI Education Institute, Inc., and the Americas Hepato-Pancreato-Biliary Association (AHPBA). CMI Education Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

accredited Provider desiGnation statementThe CMI Education Institute, Inc. designates this live educational activity for a maximum of 22.75 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ada statementIn accordance with the ADA, the CMI Education Institute, Inc. and the AHPBA will accommodate requests of special needs made in advance of the meeting, in writing.

allied HealtH symPosium AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician Assistants may receive a maximum of 22.75 hours of Category 1 Credit for completing this program.

ama Pra desiGnation statementThe CMI Education Institute, Inc. and the joint sponsor, AHPBA, will maintain full control of all aspects of the accredited CME activity titled: “The Americas Hepato-Pancreato-Biliary Association 2012 Annual Meeting” in accordance with ACCME.

learninG objectives and outcomesThe AHPBA 2012 Annual Meeting has been structured around six tracks. These represent the liver, pancreas, biliary system, liver transplantation, imaging and biomedical engineering, and general hepatobiliary (HPB) surgical disease. At the conclusion of the 2012 Annual Meeting of the AHPBA, the Association expects its attendees to have gained knowledge and skills that will lead to changes or enhancements in their own practices and improve physician training. The AHPBA expects that the 2012 Scientific Program’s educational interventions will result in measurable improvements in patient care.In addition, attendees can expect the following:Attendees will understand newest developments in clinical research in HPB diseases.

Attendees will be able to discuss quality initiatives, at the hospital and regulatory agency levels, which will impact their practices.

Attendees will be able to recognize current controversies in preoperative oncologic therapies for pancreatic and hepatic malignancies.

Attendees will be able to discern differences in training paths for a career in HPB surgery.

Attendees will recognize current, pressing research dilemmas in HPB and transplant surgery, and how these may be addressed through collaborative efforts led by the AHPBA.

Attendees will gain insight to state-of-the-art care for neuroendocrine malignancies afflicting the pancreas and liver.

Attendees will be able to judge the value of emerging technologies for care of patients in their practice.

Attendees will be able to trace the historical evolution of Hepatic and Portal Hypertension Surgery to its current state.

GoalsThe AHPBA is incorporated as a nonprofit organization and was created with vision of devoting itself to relieving the human suffering caused by HPB disorders throughout the world, by improving education, training, innovation, research and patient care.

1 Promote understanding of the causes of disorders of the liver, pancreas and biliary tree and to investigate and treat these diseases.

2 encourage the exchange of clinical and scientific knowledge among surgeons and members of related disciplines working in the field.

3 study any relevant problems that affect the liver, pancreas and biliary tract.

4 facilitate collaborative research into the factors that lead to disease in these organs and into ways of preventing it.

5 foster friendships among clinicians and scientists involved in the hepatic, pancreatic and biliary disciplines.

6 strive towards the highest ethical standards in the association’s fields of endeavor.

7 foster education and career development in the field through an identifiable funding mechanism.

Optimal Patient Care through:

education,

training,

research,

Innovation,

& Collaboration

AHPBA

Join more than 950 medical professionals in North, South and Central America specializing

in the liver, pancreas and biliary system by becoming an AHPBA member today!

For additional information, visit the AHPBA web site www.AHPBA.org

Membership BenefitsWe invite you to take part in our growing organization by becoming a member of the AHPBA. Membership in AHPBA connects you to a national and global network of medical professionals specializing in the liver, pancreas and biliary system. AHPBA boasts a diverse membership of more than 950 physicians, not only surgeons, but leading specialists within the fields of medical and radiation oncology, interventional/ diagnostic radiology, gastroenterology, pathology, transplantation and basic/ translational science. The AHPBA also welcomes Allied Health Care professionals as members. Together we meet, learn, collaborate and have fun. Besides ourselves, our patients are the ultimate beneficiaries of our endeavors.

With an array of key membership benefits, it is easy to see why so many HPB medical professionals have made the decision to join this prestigious organization.

• Membership in a large professional network of your peers

• Certificate of membership

• Discount on member mailing purchases

• Research Fellowship Grants

• AHPBA News Bulletin

• AHPBA Travel Exchange Program

• Participation in future HPB trials

• Influential fellowship match programs

• Surgical guidelines

• Annual subscription to the official journal, HPB

• Reduced registration fees to national and international meetings

• And much more...

HPB: the Official IHPBA/AHPBA Journal HPB, the official journal of the International Hepato-Pancreato-Biliary Association and its regional associations, was launched in 1999 as an international forum for scientific and social communication. Monthly issues offer readers original research, reviews, HPB images, editorials, case reports and reader correspondence connected with the various scientific and clinical interests involved in hepatic, pancreatic and biliary disease, along with the latest news from the Association. Members in good standing can access the journal online, while Active and Candidate members may also receive it by mail. HPB has just been accepted for indexing in Medline. This is a great achievement for HPB and has a significant impact on the journal’s profile and discoverability. HPB aims to help its readers - surgeons, physicians, radiologists and other scientists - to develop their knowledge and practice.

AHPBA Annual traveling Fellowship AHPBA offers two annual fellowships to members to encourage interaction, exchange of ideas and collaboration between HPB surgeons in North and South America. The North American Fellowship is open to members residing in North America and supports travel to South America (vice versa for the South American Fellowship).

Each fellowship is allotted $5,000 and is to be used to offset the cost of travel and accommodation for the Traveling Fellow. Successful applicants are to travel for one week to an HPB center in South, Central or North America.

For additional information, visit the AHPBA web site www.AHPBA.org

AHPBA.org

Para información adicional visita nuestra página de web: www.AHPBA.org

OBJetIvOSEl AHPBA se incorpora como una organización sin fines de lucro y fue creada con la visión de dedicarse a aliviar el sufrimiento humano causado por trastornos HPB en todo el mundo, mediante la mejora de la educación, la formación, la innovación, la investigación y la atención al paciente.

1 Promover el entendimiento de las causas de los trastornos del hígado, el páncreas y el árbol biliar y para investigar y tratar estas enfermedades.

2 Promover el intercambio de conocimientos clínicos y científicos entre los cirujanos y miembros de disciplinas afines que trabajan en el mismo campo.

3 estudiar los problemas relevantes que afectan al hígado, páncreas y el tracto biliar.

4 facilitar la colaboración para la investigación sobre los factores que conducen a la enfermedad en estos órganos y métodos para prevenirlas.

5 fomentar la amistad entre los médicos y los científicos involucrados en las disciplinas hepática, pancreática y biliar.

6 trabajar para alcanzar los más altos estándares éticos en los campos de las actividades de la asociación.

7 fomentar la educación y el desarrollo profesional en el campo a través de un mecanismo de apoyo financiero identificado.

AHPBA

Únete a más de 950 profesionales de la medicina del Norte, Centro y Sur América especializados en el manejo de las enfermedades del hígado, el páncreas y el sistema biliar al convertirte en un

miembro AHPBA hoy!

educacionentrenamientoInvestigaciónInnovación yColaboración

Óptimo cuidado del paciente a través de:

Beneficios para los miembrosTe invitamos a formar parte de nuestra organización en crecimiento, mediante la membrecía a la AHPBA. La membrecía en AHPBA te conecta a una red nacional y mundial de profesionales de la medicina que se especializa en el hígado, el páncreas y el sistema biliar. La AHPBA cuenta con una membrecía diversa de más de 950 médicos, no solamente cirujanos, pero también los principales especialistas en los campos de la radioterapia y oncología médica, intervención / radiodiagnóstico, gastroenterología, patología, trasplante y ciencias básicas y translacionales. El AHPBA también abre sus puertas a otros profesionales del cuidado de la salud como miembros asociados. Juntos podemos reunirnos, aprender, colaborar y divertirnos. Además de nosotros mismos, nuestros pacientes son los beneficiarios principales de nuestros esfuerzos.

Con una amplia gama de beneficios claves al ser miembro, es fácil entender por qué muchos profesionales médicos de enfermedades HPB han tomado la decisión de unirse a esta prestigiosa organización.

• Pertenecer a una gran red de profesionales

• Certificado de membrecía

• Descuento a los miembros en compras que requieran correo

• Becas de investigación

• Boletín de Noticias de la AHPBA

• Programas de viaje/intercambio de la AHPBA

• La participación en futuros ensayos clínicos del patología HPB

• Programas de sub-especialización (fellowships)

• Guías de manejo clínicas

• Suscripción anual a la revista oficial de la AHPBA: HPB

• Reducción de cuotas de inscripción para los congresos nacionales e internacionales

• Y mucho mas….

HPB: la revista oficial de la AHPBA y la IHPBA HPB, la revista oficial de la International Hepato-Pancreato-Biliary Asociation y de sus asociaciones regionales, se inició en 1999 como un foro internacional para la comunicación científica y social. Mensualmente ofrece a los lectores temas de investigación originales, comentarios, imágenes HPB, editoriales, informes de casos y correspondencia relacionada con distintos intereses científicos y clínicos en el campo de las enfermedades hepáticas, pancreáticas y biliares, junto con las últimas noticias de la Asociación. Todos los miembros al día con la Asociación tienen acceso a la revista en línea. Asimismo, los miembros Activos y Candidatos también pueden recibir la revista por correo. HPB acaba de ser aceptado para la indexación en Medline. Este es un gran logro para HPB y tiene un impacto significativo en el perfil de la revista y su exposición. HPB tiene como objetivo ayudar a sus lectores - cirujanos, médicos, radiólogos y otros científicos - a desarrollar sus propios conocimientos y práctica.

Beca/Fellowship Anual de Intercambio/viajeLa AHPBA ofrece dos becas anuales a los miembros para fomentar la interacción, el intercambio de ideas y la colaboración entre cirujanos HPB en América del Norte y Suramérica. Las Becas de América del Norte están abiertas a los miembros que residen en América del Norte y apoya los viajes a América del Sur (y viceversa para la Comunidad de América del Sur).

Cada beca es por un valor de USD $ 5.000 y se utiliza para compensar los gastos de viaje y alojamiento de la persona becada. Los candidatos elegidos serán los afortunados y viajaran durante una semana a un centro de HPB en America del Sur, América Central o América del Norte.

Para información adicional visita nuestra página de web: www.AHPBA.org

AHPBA.org


AHPBA 20122012 sPeakers & facultyeddie k. abdallaBeirut, Lebanon

David B. adamsMedical University of South Carolina

reid B. adamsUniversity of Virginia

Syed a. ahmadUniversity of Cincinnati

peter allenMemorial Sloan-Kettering Cancer Center

John allendorfColumbia University

Thomas a. aloiaMD Anderson Cancer Center

adnan a. alseidiVirginia Mason Medical Center

Domingo alvearWorld Surgical Foundation

Chandrakanth areUniversity Of Nebraska

horacio J. asbunMayo Clinic – Jacksonville

Chad g. BallUniversity of Calgary

Jose pedro BarberanUniversidad de Guayaquil

Jeffrey S.T. BarkunMcGill University

Todd w. BauerUniversity of Virginia

Stephen w. BehrmanUniversity of Tennessee

kevin e. BehrnsUniversity of Florida

Jacques BelghitiHospital Beaujon Clichy, France

David BentremNorthwestern University

eren BerberThe Cleveland ClinicBuenos Aries, Argentina

Stephen BehrmanUniversity of Tennessee

Dario eduardo BerkowskiHospital De ClinicasBuenos Aries, Argentina

anton J. BilchikCalifornia Oncology Research Institute University of California Los Angeles

rae Brana reynoldsMD Anderson Cancer Center

ross Carter C.Glasgow Royal InfirmaryGlasgow, Scotland, UK

Mark p. CalleryBeth Israel Deaconess Medical Center, Harvard University

luiz augusto Carneiro D’albuquerqueUniversity of Sao PauloSau Paulo, Brazil

Sricharan ChalikondaCleveland Clinic Foundation

Carlos ChanInsituto Nacional de la Nutricion Salvador ZubiranMexico City, Mexico

william C. ChapmanWashington University of St. Louis School of Medicine

kenneth D. ChavinMedical University of South Carolina

Daniel CherquiNew York Presbyterian Hospital-Weill Cornell Medical Center

Michael ChotiJohns Hopkins University

John D. ChristeinUniversity of Alabama at Birmingham

Quyen D. ChuLouisiana State University Health Sciences Center - Shreveport

yun Shin ChunFox Chase Cancer Center

Bryan M. ClaryDuke University Medical Center

Sean p. ClearyUniversity of Toronto

felipe Jose fernandez CoimbraHospital AC CamargoSau Paulo, Brazil

Carlos CorveraUniversity Of California San Francisco

peter CottonUniversity of South Carolina

Michael D’angelicaMemorial Sloan-Kettering Cancer Center

aram DemirjianUniversity Of California Irvine

Xabier ander de aretxabalaUniversidad de ChileSantiago Vitacura Chile


2012 sPeakers & facultyTercio de CamposSanta Casa School of Medical Sciences, Sau Paulo, Brazil

andre de MoriczSanta Casa School of Medical Sciences, Sau Paulo, Brazil

eduardo de SantibañesHospital Italiano de Buenos Aires, Argentina

Jr DelperoMarseille, France

alessandro landskron DinizHospital AC Camargo, Sau Paulo, Brazil

elijah DixonUniversity of Calgary

M. B. Majella DoyleWashington University of St. Louis School of Medicine

Jeffrey a. DrebinUniversity of Pennsylvania

Barish edilJohns Hopkins

Jean C. emondNY Presbyterian Hospital

Michael J. englesbeUniversity of Michigan

Douglas B. evansMedical College of Wisconsin

Michael B. farnellMayo Clinic – Rochester

laurean fernandez CruzHospital Clinic i Provincial de Barcelona, Spain

Cristina r. ferroneMassachusetts General Hospital

Craig p. fischerThe Methodist HospitalHouston, Texas

Jason flemingMD Anderson Cancer Center

Christos a. galanopoulosRenown Institute for CancerReno, Nevada

Steven gallingerUniversity of Toronto

T. Clark gamblinMedical College of Wisconsin

o. James gardenUniversity of EdinburghEdinburgh, Scotland, UK

Jenna gatesUniversity of Pennsylvania

william geertsSunnybrook Health Science Centre, Toronto, Canada

David a. gellerUniversity of Pittsburgh

Jean-francois h. geschwindJohn Hopkins University

Mariano eduardo gimenezHospital De ClinicasCapital Federal, Argentina

robert e glasgowThe University of Utah

nestor a. gomezUniversity of GuayaquilEquador

elizabeth goodUniversity of Virginia

paul D. greigUniversity of Toronto

andrew gumbsSummit Medical Group

ellen J. hagopianJersey Shore University Medical Center

paul hansenThe Oregon Clinic

william g. hawkinsWashington University of St. Louis School of Medicine

w. Scott heltonVirginia Mason Medical Center

alan w. hemmingUniversity of California San Diego

J. Michael hendersonThe Cleveland Clinic

paulo hermanUniversity of Sao PauloSao Paulo, Brazil

Joe hinesUniversity Of California Los Angeles

Johnny C. hongUniversity of California Los Angeles

karen horvathUniversity of Washington

Michael g. houseIndiana University

Thomas J. howardIndiana University

David iannittiCarolinas Medical Center

oscar Cesar imventarzaHospital ArgerichBuenos Aries, Argentina

Michael JacobsSt. John/Providence Health System, Novi, Michigan


AHPBA 2012

william r. JarnaginMemorial Sloan-Kettering Cancer Center

nicolas p. Jarufe CassisPontificia Universidad Catolica De ChileSantiago, Chile

D. rohan JeyarajahMethodist Dallas Medical Center

Shalini rao kannegantiLegacy Health System, Portland, Oregon

Matthew h. katzMD Anderson Cancer Center

Michael l. kendrickMayo Clinic – Rochester

rebecca keimAlbany Liver And Pancreas Surgery

Tara S. kentBeth Israel Deaconess Medical Center – Harvard University

eric T. kimchiPenn State Milton S. Hershey Medical Center

kimberly kirkwoodUniversity of California San Francisco

alan J koffronWilliam Beaumont Hospital Royal Oaks, Michigan

eric kortzSwedish Medical Center

Sean kumerUniversity Of Kansas

harish lavuThomas Jefferson University

Javier lendoireHospital Dr. Cosme ArgerichBuenos Aires, Argentina

keith D. lillemoeMassachusetts General Hospital

J. peter a. lodgeSt. James’s University Hospital, Leeds, UK

andrew M. lowyUniversity of California San Deigo

Shishir k. MaithelEmory University

John MansourUniversity of Texas Southwestern Medical Center

Stuart g. MarcusSt. Vincent HospitalBridgeport, Connecticut

robert MartinUniversity of Louisville

John MartinieCarolinas Medical Center

Jeffrey B. MatthewsThe University of Chicago

lucas McCormackHospital Aleman of Buenos Aires, Argentina

ian McgilvrayUniversity of Toronto

Miguel-angel MercadoInsituto Nacional de la Nutricion Salvador ZubiranMexico City, Mexico

nipun B. MerchantVanderbilt University

peter MetrakosMontreal, Canada

rebecca M. MinterUniversity of Michigan

ernesto p. MolmentiNorth Shore - Long Island Jewish Health System, NY

katherine MorganMedical University of South Carolina

a. James MoserBeth Israel Deaconess Medical Center, Harvard University

Sean J. MulvihillUniversity of Utah

kathleen MurrayBeth Israel Deaconess Medical Center, Harvard University

David M. nagorneyMayo Clinic – Rochester

attila nakeebIndiana University

Bill nealonVanderbilt University Medical Center

Jeffrey a. nortonStanford University

Susan l. orloffOregon Health & Science University

Timothy M. pawlikJohns Hopkins University

ivan pedrosaUniversity of Texas Southwestern Medical Center

Juan pekoljHospital Italiano Buenos Aires, Argentina

C. wright pinsonVanderbilt University Medical Center

2012 sPeakers & faculty


2012 sPeakers & facultyhenry a. pittIndiana University

howard a. reberUniversity of California Los Angeles

Diane reidyMemorial Sloan-Kettering Cancer Center

alexander rosemurgyTampa General Medical Group, Tampa, Florida

nael Saad, MDWashington University, St. Louis

eduardo de SantibañesHospital Italiano De Buenos Aires

Juan M. SarmientoEmory University

Michael g. SarrMayo Clinic – Rochester

richard D. SchulickJohns Hopkins University

roderich e. SchwarzUniversity of Texas Southwestern Medical Center

Shimul ShahUniversity of Massachusetts Medical School

Margo C. ShoupLoyola University Medical Center

Diane M. SimeoneUniversity of Michigan

kevin f. Staveley-o’CarrollPenn State Milton S. Hershey Medical Center

Julie a. SteinWilliam Beaumont Hospital Royal Oaks, Michigan

Steven M. StrasbergWashington University of St. Louis School of Medicine

Mark S. TalamontiNorthshore University Health System – Northwestern University

a. Joseph TectorIndiana University School of Medicine

John p. ThomasSouth Plains Surgical Associates, Lubbock, Texas

lee w. ThompsonCancer Surgery of MobileMobile, Alabama

giles ToogoodSt. James University Hospital Leeds, UK

Susan TsaiMedical College of Wisconsin

Jennifer f. TsengBeth Israel Deaconess Medical Center, Harvard University

Douglas S. TylerDuke University Medical Center

Tsafrir VanounouJewish General HospitalMontreal, Canada

Caroline VerbekeKarolinska Institute, Sweden

leonardo VillegasSacred Heart Health System, Pensacola, Florida

Charles M. VollmerUniversity of Pennsylvania

kevin watkinsStony Brook University Medical Center

Sharon M. weberUniversity of Wisconsin

Steven h. weiMD Anderson Cancer Center

emly r. winslowUniversity of Wisconsin

Christopher l. wolfgangJohns Hopkins University

Charles J. yeoThomas Jefferson University

herbert J. zehUniversity of Pittsburgh

gazi B. zibariLouisiana State University Health Sciences Center - Shreveport

randy zuckermanSt Vincents Medical Center

nicholas J. zyromskiIndiana University


AHPBA 2012

AHPBA 2012Impacting Your HPB Practice

12th AnnuAl meeting of the AmericAs hepAto–pAncreAto–biliAry AssociAtion


HIBISCUS

BAYSHORE

STAR

PALM

LIL GORCE

KEY BISCAYNE

A

KEY BISCAYNE

B

FISHER A

FISHER B

BELLE

SAN MARCO

SAN MARINO

EX

EC

UT

IVE

B

OA

RD

RO

OM

RIVO ALTO

PALLADIIUM

BUSINESS CENTER

GROUP OFFICE

Lower Lobby Level

Conference Level

Mezzanine Level

Hotel floor Plan


AHPBA 2012

POMPEII BALLROOM

PROMENADE ROOM

MONA LISA FOYER

MONA LISA

RECEPTION

LOBBY

RESTAURANT

PROMENADE FOYER

Lobby Level

A B

Hotel floor Plan

OCEAN BALLROOM

IIA

OCEAN BALLROOM

IIB

OCEAN BALLROOM

IIC

LAPIDUS

WATSON

OCEAN BALLROOM

IA

OCEAN BALLROOM

IB

OCEAN BALLROOM

IC

Penthouse FloorOcean Tower

SUNNY ISLES BAL

HARBOUR

WATER VEIW

TERRACE


WEDNESDAY8:30 aM - 2:45 pM pre ConferenCe SporTing eVenTS

4th Annual Golf Tournament Location: Miami Beach Golf Club Sponsored by: Microsulis

3rd Annual Fishing Tournament Location: Haulover Park

7:30 aM Ultrasound course Registration and pre-testContinental Breakfast providedRoom: Palm

8:00 aM - 12:00 pM ulTraSounD anD aDVanCeD hpB TeChnology - DiDaCTiC porTion (additional fee)Room: PalmCourse Director: Ellen Hagopian

8:00 - 8:10 am Introduction/ Welcome/ Pretest – Ellen Hagopian

8:10 - 8:20 am Importance of Ultrasound in HPB Surgery – Ellen Hagopian

8:20 - 8:40 am Principles and Instrumentation – Eren Berber

8:40 - 9:10 am Normal Pancreatobiliary Anatomy – Scott Helton

9:10 - 9:40 am Normal Liver Anatomy – Leonardo Villegas

9:40 - 10:00 am Pathologic Findings in HPB Diseases – Dario Berkowski

10:00 - 10:15 am Refreshment Break

10:15 - 10:35 am Ultrasound Scanning Methods and Techniques – Reid Adams

10:35 - 10:55 am Techniques in Ultrasound Guidance – David Iannitti

10:55 - 11:15 am Liver Navigation – W. Chapman

11:15 - 11:35 pm Principles of Tumor Ablation – Paul Hansen

11:35 - 11:50 am Panel Discussion – All speakers

11:50 am - 12:00 pm Introduction to Hands-On Sessions – Ellen Hagopian

12:00 - 1:00 pm Buffet Lunch in the Spa Garden

1:00 - 4:45 pm ulTraSounD hanDS-on workShop Room: Key Biscayne A-B

1:00 - 2:30 pm HPB Ultrasound Anatomy and Technique

2:30 - 2:45 pm Refreshment Break

2:45 - 4:45 pm Techniques/Technology in Ultrasound Guidance and Liver Surgery

4:45 - 5:00 pM poST TeST

The AHPBA would like to thank BK Medical, Hitachi Aloka Medical, Ltd., and Pathfinder for their sponsorship.

In-kind support provided by:Boston Scientific Covidien Ethicon Endo-Surgery Karl Storz - Endoskope Kyoto Kagaku


WEDNESDAY3:00 - 7:00 pm AHPBA Committee Meetings

4:00 - 6:00 pM allieD healTh Care SyMpoSiuMRoom: PalmModerator: Timothy Pawlik and Steven Wei

Overview of the Mid-Level Providers: Defining roles of MLP, what they have to offer, their skill set – Steven Wei

Mid-Level Providers and Outpatient Care: Defining role of MLP in the outpatient setting – Elizabeth Good

Mid-Level Providers and Inpatient Care: Defining role of MLP in the inpatient setting – Jenna Gates

Long-term Surveillance Programs: the role of Mid-Level Providers. Defining role of MLP in surveillance programs such as “Pancreas Cyst Clinics” or “Survivorship Clinics” – Rae Brana Reynolds

Session overview: This session will provide an understanding of the several roles and responsibilities that Physician Assistants (PAs) and Nurse Practitioners (NPs) fulfill in the complex management of the HBP patient. It will provide a foundation of knowledge of a midlevel provider’s scope of practice and how they can be integrated into the outpatient and inpatient setting. Emphasis will be on pre- and post-operative care, medical management, and long-term surveillance processes.

6:00 - 7:00 pm Dinner Buffet for Allied Health & Committee MembersRoom: Belle

6:00 - 8:00 pm Registration DeskLocation: Ocean Tower 1 Foyer

7:30 - 9:30 pm AHPBA Executive Council MeetingRoom: Lapidus/Watson (on penthouse floor level)


THURSDAY7:00 - 9:00 am Executive Council Meeting Continues

Room: Lapidus / Watson

7:00 am - 5:30 pm Registration Desk Location: Ocean Tower 1 Foyer

9:00 - 10:00 am IHPBA/Kenneth Warren Foundation MeetingContinental Breakfast will be servedRoom: Executive Board Room (Lower Level)

10:00 am - 5:30 pm ahpBa poSTgraDuaTe CourSe Room: Ocean Tower I A-C Exclusive Sponsor: Ethicon Endo-Surgery

10:00 - 11:30 am Session I: Liver/Transplantation Case PresentationsModerator: Will ChapmanPanelists: Jacques Belghiti, Al Hemming, Eduardo de Santibañes, Peter Metrakos,

Michael D’AngelicaRadiologist: Ivan Pedrosa

11:30 am - 1:00 pm Lunch - On your own at hotel restaurants1500 Restaurant or Charley Cabana Grill

12:00 - 1:00 pm Candidate / Young Attendees, New Members & Allied Health ProgramLocation: Waterview Terrace

Lunch will be provided by the AHPBA

Program supported by Ethicon Endo-Surgery

1:00 - 3:00 pm Session II: Pancreas Case Presentations Moderator: Charles VollmerPanelists: Charles Yeo, Peter Allen, Jeff Barkun, Ross Carter, JR DelperoRadiologist: Ivan Pedrosa

3:00 pm Refreshment Break

3:30 - 5:30 pm Session III: Liver/Biliary Case Presentations Moderator: Bill JarnaginPanelists: David Nagorney, James Garden, Juan Pekolj, David Geller, Peter LodgeRadiologist: Ivan Pedrosa

5:00 pm SCORE Curriculum Meeting with FellowsRoom: Belle

5:30 - 7:00 pm Welcome Reception in the Exhibit HallHors d’oeuvres and complimentary beer and wine served Room: Pompeii/Promenade


THURSDAY7:00 - 9:00 pm Covidien Sponsored Dinner Symposium (no CME credits provided)

Room: Ocean Tower I A-C

improving outcomes by advancing MiS and Multidisciplinary Management in hpB SurgeryFaculty: David Iannitti, MD, David Geller, MD, Nipun Merchant, MD

laparoscopic liver Surgery - Update on the current evidence, outcomes and benefits

pancreatic resection

Minimally invasive distal pancreatectomy - Evidence on outcomes, advances in techniques and management of complications

Cancer of the head of the pancreas - Multidisciplinary management and surgical techniques to optimize negative margin resection

Multidisciplinary hpB program Development, including programmatic and economic elements

7:00 - 10:00 pm fellowS/reSiDenTS SyMpoSiuM Room: Ocean Tower II A-BCoordinators: Rohan Jeyarajah & Paul Hansen

providing a Backdrop: what’s new in Surgical education

Changes in General Surgery Training – O. Joe Hines

Where are we Going With Fellowship Training? – Rebecca Minter

Are We HPB Surgeons or Advanced GI Surgeons? – Mike Sarr

what are the Components of a Successful hpB program

The Academic Model – Keith Lillemoe

What are the Differences Between Private and Academic Settings? – Rohan Jeyarajah

lessons learned: recent graduate presentations

Setting Up HPB in a Hybrid Environment – Kevin Lowe

Purely Private Practice – Rebecca Keim

Academic Medicine – Emily Winslow

Panel Session With the Leaders – Panel Members


FRIDAY6:30 am - 5:00 pm

Registration DeskLocation: Ocean Tower 1 Foyer

6:30 - 7:35 am Medtronic Advanced Energy Sponsored Breakfast Symposium (formerly Salient Surgical Technologies) (no CME credits provided)

Rooms: Ocean Tower II A/B

reducing pancreatic leaks – Tips & TechniquesFaculty: Nipun B. Merchant, John Martinie, Lee W. Thompson

7:45 - 7:50 AM 2012 Meeting WelcomeRoom: Ocean Tower 1 A-CCharles M Vollmer, 2012 Program Chair

7:50 -10:15 aM preSiDenT’S plenary SeSSionRoom: Ocean Tower I A-C

7:50 - 7:55 am Introduction of the President William Jarnagin

7:55 - 8:30 am President’s Address: From Couinaud to Molecular Biology: The Seven Virtues of HPB Surgery

Jean-Nicolas Vauthey Professor of Surgery Chief, Liver Service MD Anderson Cancer Center

2012 Distinguished Service Award PresentationPaul D. Greig, MDUniversity of Toronto

8:30 - 8:40 am HPB Completion of Certificate Presentation Jean-Nicolas Vauthey, Rebecca Minter

8:40 - 10:15 am President’s Plenary Session with Research and Traveling Fellowship PresentationsModerator: Jean-Nicolas Vauthey

PPYI.01 EFFICACY AND COST-BENEFIT ANALYSIS OF MESH REINFORCEMENT OF STAPLED LEFT PANCREATECTOMY: RESULTS OF A RANDOMIZED CONTROLLED TRIALK. Idrees1, J. R. Edler2, D. C. Linehan1, S. M. Strasberg1, N. A. Hamilton1, R. Fields1, D. Lambert2, S. Kymes2, W. G. Hawkins1; 1Department Of Surgery, Washington University, St. Louis, MO; 2Center For Economic Evaluation In Medicine, Washington University, St. Louis, MODiscussant: Scott Helton

Traveling fellowship report – Carlos Chan


FRIDAY7:50 -10:15 am President’s Plenary Session Room: Ocean Tower I A-C Continued

PPYI.02 CENTER VOLUME AND RESOURCE CONSUMPTION IN LIVER TRANSPLANTATIONC. W. Macomber1, J. J. Shaw1, H. Santry1, R. F. Saidi1, N. Jabbour1, A. Bozorgzadeh1, J. F. Tseng1, S. A. Shah1; 1Surgical Outcomes Analysis & Research, UMass Medical School, Worcester, MADiscussant: J. Michael Henderson

Traveling fellowship report – Michele Molinari

PPYI.03 A 21-YEAR ANALYSIS OF T1 GALLBLADDER CARCINOMA: IS CHOLECYSTECTOMY ALONE ADEQUATE?D. M. Hari1, J. Howard1, C. G. Chiu1, A. M. Leung1, M. Sim1, A. J. Bilchik1,2,3; 1John Wayne Cancer Institute, Santa Monica, CA; 2David Geffen School Of Medicine At University Of CA, Los Angeles, CA; 3CA Oncology Research Institute, Los Angeles, CADiscussant: Reid Adams

Traveling fellowship report – Alessandro Diniz

PPYI.04 RISK OF VENOUS THROMBOEMBOLISM OUTWEIGHS POST-HEPATECTOMY BLEEDING COMPLICATIONS: ANALYSIS OF 5,651 NSQIP PATIENTSC. D. Tzeng1, M. H. Katz1, J. B. Fleming1, P. W. Pisters1, J. E. Lee1, E. K. Abdalla1, S. A. Curley1, J. N. Vauthey1, T. A. Aloia1; 1The University Of Texas MD Anderson Cancer Center, Houston, TXDiscussant: Sean Mulvihill

2011 research fellowship award update – Michelle Babicky

10:15 - 10:30 am Coffee Break – Location: Ocean Tower I Foyer

10:30 - 11:00 aM parallel STaTe-of-The-arT leCTureS

Risk Prediction for Pancreatectomy Room: Ocean Tower I A-C Introduction: Chris Wolfgang Speaker: Jennifer Tseng

Hepatic Steatosis for the HPB Surgeon Room: Ocean Tower II A/B Introduction: William Chapman Speaker: Kenneth Chavin

11:00 aM - 12:30 pM parallel SyMpoSia

Quality in hpB SurgeryRoom: Ocean Tower I A-C Moderators: Roderich Schwarz & Henry Pitt

Bench to Bedside hpB TechnologyRoom: Ocean Tower II – A/B Moderators: David Iannitti & Tsafrir Vanounou

What is Surgical Quality? – J. Michael Henderson Introduction of New Technology Into Clinical Practice – Steven Strasberg

Regulatory Demands on You and Your Hospital – Kathleen Murray

Proteomics, Genomics, Chemosensitivity Testing – Susan Tsai

Quality in HPB – Sean Mulvihill Status of Xenotransplantation – A. Joseph Tector

Cancer Care Quality – John Mansour Future of Robotic Surgery – Christos Galanopolous

Transplant Quality – Mike Englesbe Status and Direction of Image Guidance – John Martinie

Ablation Therapies – RF, Bipolar, MW, IRE – Oh My! – Anton Bilchik


FRIDAY12:30 - 1:30 pM parallel lunCh eVenTS

lunch with the professors You may still purchase tickets for this event at the Registration Desk.Location: Waterview Terrace

lunch with the exhibitorsRoom: Pompeii

Exhibit Hall remains open until 7:30 pm

Transplant Across the Americas Oscar Imventarza & Susan Orloff

Building Your Academic Portfolio David Geller & Kevin Behrns

Operations for Chronic Pancreatitis Katy Morgan & Bill Nealon

Approaches to Bile Duct Injuries Miguel Mercado & Steve Gallinger

1:30 - 2:00 pm Invited Presidential Lecturer

Hepatic Surgery: Past, Present, and Future Room: Ocean Tower I A-CIntroduction: Jean Nicolas VautheySpeaker: David Nagorney

2:00 - 2:30 pm Historical Lecture

Treatment of Portal Hypertension Room: Ocean Tower I A-C Introduction: Miguel Mercado Speaker: J. Michael Henderson

2:30 – 3:15 pM parallel upDaTe leCTureS

The New Classification of Acute Pancreatitis Room: Ocean Tower I A-C Introduction: Attila Nakeeb Speaker: Michael Sarr Rebuttal / Opinion: Karen Horvath

Portal Vein Embolization Room: Ocean Tower II A/B Introduction: Sean Cleary Speaker: Eddie Abdalla Rebutal / Opinion: Jacques Belghiti

3:15 - 4:00 pM DeBaTe

Neoadjuvant Therapy is the Standard of Care for Pancreatic Cancer Room: Ocean Tower I A-CModerators: Doug Tyler and Stuart Marcus

PRO – Doug Evans CON – Mark Callery


FRIDAY4:15 - 5:30 pM parallel SyMpoSia

Building your hpB programRoom: Ocean Tower I A-C Moderators: Tara Kent & Keith Lillemoe

ahpBa on the road: international Medical CharityRoom: Ocean Tower II A/B Moderators: Gazi Zibari & Nestor Gomez

Value of HPB to the Department and Hospital – Jeff Drebin

A Review of the AHPBA Conference in Ecuador – Nestor Gomez

The Community Practice Model Randy Zuckerman

Two Decades of Medical Charity Work in Kurdistan of Iraq: From Fact Finding Mission to Capacity Building – Gazi Zibari

Mid-level Providers in Your Practice Jenna Gates

Surgical Mission Surprises: How to Manage Them Out of Our “Comfort Zone”? – Domingo Alvear

Playing in the Sandbox Together: Multidisciplinary Integration – Peter Cotton

Surgeons as “Ambassadors” through Surgical Volunteerism – Quyen Chu

Developing a Research Program – Diane Simeone Operation Hope Medical Missions: Magnitude of Problem and Lessons Learned – John ThomasSo You Want a Fellow? – Rohan Jeyarajah

5:00 - 6:30 pM oral poSTer i preSenTaTion Room: Promenade

Oral Poster I Pancreas I Moderator: Courtney Scaife

OP-A1.01 SURROGATE ONCOLOGIC MARKERS FOR LONG TERM SURVIVAL ARE IMPROVED WITH THE USE OF MINIMAL ACCESS SURGERY FOR PANCREATIC CANCERJ. A. Stauffer1, A. Rosales-Velderrain1, R. F. Goldberg1, T. Clarke1, M. Buchanan1, S. P. Bowers1, H. J. Asbun1; 1Mayo Clinic Florida, Jacksonville, FL

OP-A1.02 REDUCED POST-OPERATIVE COMPLICATIONS WITH LAPAROSCOPIC VERSUS OPEN DISTAL PANCREATECTOMY: A META-ANALYSISS. A. Chadi1, K. P. Croome1, C. Schlachta1, R. Hernandez-Alejandro1; 1University Of Western Ontario, London, ON

OP-A1.03 CLINICAL OUTCOMES OF ANAPLASTIC PANCREATIC CANCERJ. Arun1, C. Clark1, R. Graham1, K. M. Reid-Lombardo1; 1Mayo Clinic, Rochester, MN

OP-A1.04 A COMPARISON OF CLINICOPATHOLOGICAL FEATURES AND LONG-TERM SURVIVAL FOR RESECTED PERIAMPULLARY ADENOCARCINOMASJ. He1, N. Ahuja1, M. A. Makary1, J. L. Cameron1, T. M. Pawlik1, M. A. Choti1, R. H. Hruban2, R. D. Schulick1, B. H. Edil1, C. L. Wolfgang1; 1Johns Hopkins Medical Institutions, Department Of Surgery, Baltimore, MD; 2Johns Hopkins Medical Institutions, Department Of Pathology, Baltimore, MD

OP-A1.05 READMISSION FOLLOWING PANCREATECTOMY: WHAT CAN WE DO BETTER?S. Gondek1, C. C. Glass1, C. M. Vollmer2, M. P. Callery1, T. S. Kent1; 1Beth Israel Deaconess Medical Center / Harvard Medical School, Boston, MA; 2University Of Pennsylvania Dept Of Surgery, Philadelphia, PA

OP-A1.06 HEPATIC ARTERIAL NODAL METASTASES IN PANCREATIC CANCER: IS THIS THE NODE OF IMPORTANCE?J. LaFemina1, C. Correa-Gallego1, J. F. Chou1, M. Gonen1, T. P. Kingham1, R. P. DeMatteo1, M. D’Angelica1, W. R. Jarnagin1, P. J. Allen1; 1Memorial Sloan-Kettering Cancer Center, New York, NY

OP-A1.07 MULTIDISCIPLINARY MANAGEMENT OF PANCREATIC VIPOMAS: EXPERIENCE FROM A LARGE REFERRAL CENTERS. G. De La Fuente1, A. S. Cheema1, J. R. Strosberg1, D. Coppola1, J. Weber1, P. J. Hodul1, M. Malafa1, L. K. Kvols1; 1H. Lee Moffitt Cancer Center, Tampa, FL

Continued next page


FRIDAY5:00 - 6:30 pm Oral Poster 1 Presentation Room: Promenade Continued

OP-A1.08 107 PANCREATIC RESECTIONS : FACTORS AFFECTING MORTALITY AND MORBIDITYV. M. Thumma1, N. Bheerappa1, R. A. Sastry1; 1Nizam’s Institute Of Medical Sciences, Hyderabad

Oral Poster 1 LiverModerator: Purvi Parikh

OP-A2.01 POSTOPERATIVE VENOUS THROMBOEMBOLISM FOLLOWING HEPATECTOMY: A NATIONWIDE ANALYSIS TO EXTEND THE CASE FOR ROUTINE PROPHYLAXISD. J. LaPar1, D. M. Walters1, T. W. Bauer1, S. C. Kumer1, R. B. Adams1, K. L. Brayman1, T. M. Schmitt1; 1University Of Virginia, Charlottesville, VA

OP-A2.02 INHIBITION OF CASPASES 3/7 ENZYME ACTIVITY WITH AN INFUSION OF TIMP-3 MINIMIZES APOPTOSIS IN NORMAL LIVERS DURING SUB-LETHAL TOTAL HEPATIC ISCHEMIA IN RATSC. P. Zetzmann1, M. Shuh1, G. E. Loss2, H. Bohorquez2, A. J. Cohen1,2; 1Transplantation Research Laboratory, New Orleans, LA; 2Multi-Organ Transplant Center, New Orleans, LA

OP-A2.03 A DECADE OF MIMINALLY INVASIVE LIVER RESECTION (MILR) IN 432 PATIENTS AT A HIGH VOLUME LIVER CANCER CENTERJ. S. Cardinal1, A. Tsung1, J. Marsh1, S. Reddy1, D. L. Bartlett1, D. A. Geller1; 1University Of Pittsburgh Medical Center Department Of Surgery, Pittsburgh, PA

OP-A2.04 TWO-STAGE LIVER RESECTION IN COLORECTAL CANCER (CRC) LIVER METASTASIS: SELECTION, MICROMETASTASIS AND PROGNOSIS.L. T. Seeberg1, G. Wiedswang1, K. W. Brudvik1, B. A. Bjrnbeth1, H. Hugenschmidt1, K. J. Labori1, B. Naume1, N. E. Klw1, A. Waage1; 1Oslo University Hospital, Oslo, OSLO

OP-A2.05 ROLE OF OPERATIVE THERAPY IN TREATMENT OF INTRA AND EXTRAHEPATIC METASTATIC HEPATOCELLULAR CARCINOMA IN PATIENTS WITHOUT CIRRHOSIS.V. Zaydfudim1, R. L. Smoot1, M. L. Kendrick1, F. G. Que1, M. B. Farnell1, D. M. Nagorney1; 1Mayo Clinic, Rochester, MN

OP-A2.06 HCC: RESECT OR TRANSPLANTR. PIeretti- Vanmarcke1,2, U. Basit1, M. Ligorio1,2, N. Elias1,2, D. L. Berger1,2, K. K. Tanabe1,2, C. R. Ferrone1,2; 1Massachusetts General Hospital, Boston, MA; 2Harvard Medical School, Boston, MA

OP-A2.07 EVALUATION OF A NOVEL BIOCERAMIC DRUG DELIVERY SYSTEM FOR TREATING HEPATOCELLULAR CARCINOMA (HCC) IN VIVOJ. H. Swet1,2, H. G. Pacheco2, A. El-Ghannam2, D. Sindram1, J. B. Martinie1, D. A. Iannitti1, I. H. McKillop1; 1Carolinas Medical Center, Charlotte, NC; 2UNC At Charlotte, Charlotte, NC

OP-A2.08 MASSIVE HEPATOCELLULAR CARCINOMA IS ASSOCIATED WITH YOUNG, CHRONIC HEPATITIS B CARRIERS WITH NON-CIRRHOTIC LIVERSU. Sarpel1, D. M. Ayo1, I. V. Lobach1, R. Xu1, E. Newman1; 1New York University Medical Center, New York, NY

OP-A2.09 MICROWAVE ABLATION FOR CIRRHOTIC PATIENTS WITH HEPATOCELLULAR CARCINOMA WITH AND WITHOUT COMBINATION OF OTHER LIVER DIRECTED THERAPIES: LONG TERM FOLLOW UPE. Feinberg1, M. Vivanco1, S. Bellemare1, M. Kinkhabwala1, J. Chapochnick Friedmann1; 1Montefiore Medical Center / Albert Einstein College Of Medicine, Bronx, NY

OP-A2.10 UTILIZATION AND OUTCOMES OF PATIENTS WITH COLORECTAL LIVER METASTASES IN THE MEDICARE POPULATIONC. W. Macomber1, S. Ng1, Y. Li1, K. Alavi1, H. Santry1, J. F. Tseng1, S. A. Shah1; 1Surgical Outcomes Analysis & Research, UMass Medical School, Worcester, MA



Oral Poster I Biliary/Other IModerator: Sam Pappas

OP-A3.01 BILE DUCT INVOLVEMENT PORTENDS POOR PROGNOSIS IN RESECTED GALLBLADDER CARCINOMAR. L. Eil1, P. D. Hansen2, M. Cassera1, S. L. Orloff1, B. C. Sheppard1, B. Diggs1, K. G. Billingsley1; 1Division Of Surgical Oncology, Oregon Health And Sciences University, Portland, OR; 2Hepatobiliary And Pancreatic Surgery Program, Providence Portland Medical Center, Portland, OR

OP-A3.02 SURGICAL MANAGEMENT TRENDS FOR CHOLANGIOCARCINOMA IN THE UNITED STATES 1998-2009J. Anderson1, K. Mekeel1, D. C. Chang1, M. Talamini1, A. W. Hemming1; 1University Of CA, San Diego, San Diego, CA

OP-A3.03 PREOPERATIVE IMAGING FINDINGS CONCERNING FOR GALLBLADDER MALIGNANCY: IS INITIAL LAPAROSCOPIC APPROACH TO RESECTION REASONABLE? G. Wright1, A. Siripong1, M. D. Winton3, E. J. Mitchell1, M. H. Chung1,2 ; 1Grand Rapids Medical Education Partners/Michigan State Univ General Surgery Residency Program, Grand Rapids, MI; 2Spectrum Health Medical Group, Grand Rapids, MI; 3Michigan State University College Of Human Medicine, Grand Rapids, MI

OP-A3.04 FACTORS ASSOCIATED WITH READMISSION FOLLOWING COMPLEX HEPATO-PANCREATO-BILIARY OPERATIONSJ. C. Mansour1, O. Jaffer1, A. C. Yopp1, R. R. Sharma1, C. McGilvray1, G. C. Balch1, R. E. Schwarz1; 1University Of Texas Southwestern, Dallas, TX

OP-A3.05 REDUCING SURGICAL SITE INFECTIONS IN HEPATO-PANCREATO-BILIARY SURGERYE. P. Ceppa1, M. G. House1, H. A. Pitt1, E. M. Kilbane1, S. K. Janitz1, A. Nakeeb1, T. J. Howard1, C. M. Schmidt1, M. A. Maluccio1, N. J. Zyromski1, K. D. Lillemoe2; 1Indiana University Medical Center, Indianapolis, IN; 2Massachusets General Hospital, Boston, MA

OP-A3.06 INITIAL EXPERIENCE WITH A COMPREHENSIVE TISSUE BIOBANKING PROGRAM FOCUSING ON COMPLEX GASTROINTESTINAL CANCER RESECTIONSJ. C. Mansour1, C. M. Lewis1, G. C. Balch1, A. C. Yopp1, C. McGilvray1, R. R. Sharma1, R. E. Schwarz1; 1University Of Texas Southwestern, Dallas, TX

OP-A3.07 PANCREATICODUODENECTOMY: 22 YEAR COMPARATIVE OUTCOME ANALYSIS IN A SINGLE INSTITUTION AND THE EFFECT OF ACQUIRING A FELLOWSHIP TRAINED HEPATICOPANCREATICOBILIARY SURGEONA. Kamyab1, L. Bolo1, M. J. Jacobs1; 1Providence Hospital And Medical Centers, Southfield, MI

OP-A3.08 RISK FACTORS FOR DELAYED GASTRIC EMPTYING AFTER PANCREATICODUODENECTOMYV. M. Thumma1, N. Bheerappa1, R. A. Sastry1; 1Nizam’s Institute Of Medical Sciences, Hyderabad, Ap

Oral Poster I TransplantModerator: Sean Kumer

OP-A4.01 DONOR-DERIVED METASTATIC PARAGANGLIOMA IN A LIVER TRANSPLANT RECIPIENT: DIAGNOSIS AND TREATMENTA. Zarrinpar1, J. R. Hiatt1, R. W. Busuttil1; 1The Dumont-UCLA Transplant Center, Los Angeles, CA

OP-A4.02 RESECTION VERSUS TRANSPLANT FOR SOLITARY HEPATITIS C-ASSOCIATED HEPATOCELLULAR CARCINOMA: AN INTENTION-TO-TREAT ANALYSISB. Shrager2; 1Recanati-Miller Transplantation Institute, Mount Sinai School Of Medicine, New York, NY; 2Division Of Surgical Oncology, Department Of Surgery, Mount Sinai School Of Medicine, New York, NY; 3Division Of Liver Disease, Department Of Medicine, Mount Sinai School Of Medicine, New York, NY

Continued next page



Oral Poster I Transplant Continued

OP-A4.03 THE PROGNOSTIC UTILITY OF FDG-PET CT IN THE EVALUATION OF PATIENTS WITH HEPATOCELLULAR CARCINOMA FOR LIVER TRANSPLANTATIONE. Simoneau1, M. Jamal1, M. Aljiffry1, A. Salman1, J. Kwan1, P. Chaudhury1, J. Tchervenkov1, P. Metrakos1, M. Hassanain1,2; 1McGill University Health Center, Montreal, QC; 2King Saud University, Riyadh, Riyadh

OP-A4.04 HEPATIC RESECTION OFFERS SIMILAR OVERALL SURVIVAL TO TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMAT. M. Earl1,2, S. Naugler1,2, D. Scott1,2, K. Roayaie1,2, K. Billingsley1,2, A. Zaman1,2, M. Chang1,2, A. W. Sasaki1,2, B. Sheppard1,2, S. L. Orloff1,2; 1Oregon Health And Science University, Portland, OR; 2Portland VA Medical Center, Portland, OR

OP-A4.05 X RESULTS OF SIMULTAENOUS LIVER-KIDNEY TRANSPLANT: SINGLE CENTER REVIEWE. C. Maynard1, W. Chapman1, S. Shenoy1, N. Vachharajanin1, M. Henn1, J. Lowell1, J. Wellen1, Y. Lin1, M. M. Doyle1; 1Washington University Department Of Abdominal Transplantation, St. Louis, MO

OP-A4.06 PATIENT AND COMMUNITY CHARACTERISTICS ARE ASSOCIATED WITH LONGITUDINAL HEALTH-RELATED QUALITY OF LIFE IN LIVER TRANSPLANT RECIPIENTSL. Redhage1, I. D. Feurer1, D. E. Moore1, L. Simmons1, C. W. Pinson1; 1Vanderbilt University Transplant Center, Nashville, TN

OP-A4.07 SUCCESSFUL ABDOMINAL ORGAN DONATION AFTER BRAIN DEATH IN A PATIENT WITH A BIVENTRICULAR ASSIST DEVICE: EXTENDING EXTENDED CRITERIAS. G. Carpenter1, D. E. Steidley2, D. D. Douglas3, S. Reddy1, D. C. Mulligan3, A. A. Moss1; 1Mayo Clinic Arizona, Division Of Transplant Surgery, Phoenix, AZ; 2Mayo Clinic Arizona, Department Of Cardiovascular Diseases, Phoenix, AZ; 3Mayo Clinic Arizona, Division Of Transplant Hepatology, Phoenix, AZ

Oral Poster I Liver IIModerator: Ted Welling

OP-A5.01 KI-67 INDEX PREDICTS PROGRESSION FREE SURVIVAL IN PRIMARY PANCRAETIC NEUROENDOCRINE TUMORS AND NEUROENDOCRINE LIVER METASTASES.S. J. Temple1, E. Morin2, S. Serra3, P. T. Kim1, A. C. Wei1, S. Gallinger1, C. Moulton1, P. D. Greig1, S. Asa3, S. Ezzat2, S. P. Cleary1; 1Department Of Surgery, Toronto, ON; 2Department Of Medicine, Toronto, O; 3Department Of Pathology, Toronto, ON; 4Department Of Oncology, Toronto, ON

OP-A5.02 ARE HEPATOCELLULAR CARCINOMA PATIENTS MORE LIKELY TO RECEIVE LIVER RESECTION IN REGIONS WITH LONGER TRANSPLANT WAIT-TIMES?J. Anderson1, K. Mekeel1, D. C. Chang1, M. Talamini1, A. W. Hemming1; 1University Of CA, San Diego, San Diego, CA

OP-A5.03 TRIPTOLIDE-INDUCED CELL DEATH IN HEPATOCELLULAR CARCINOMAT. C. Krosch1, V. Sangwan1, S. Banerjee1, A. K. Saluja1, E. H. Jensen1, S. M. Vickers1; 1University Of Minnesota Department Of Surgery, Minneapolis, MN

OP-A5.04 SPONTANEOUS RUPTURE OF PYOGENIC LIVER ABSCESS - AN ASIAN PERSPECTIVES. Y. Lee 1,2, C. Chia2, Y. M. Tan1; 1Department Of Surgical Oncology, National Cancer Centre, Singapore, Singapore, Singapore; 2Department Of General Surgery, Singapore General Hospital, Singapore, Singapore, Singapore

OP-A5.05 TWO CASES OF SPONTANEOUS REGRESSION OF HEPATOCELLULAR CARCINOMA WITH EXTRAHEPATIC METASTASISC. Takeura1, T. Tokoro1, Y. Tanahashi1, J. Yoshida1, T. Kagawa1, Y. Kato1, A. Sugioka1; 1Department Of Surgery, Fujita Health University, Toyoake, AICHI

OP-A5.06 THE UTILITY OF POSITRON EMISSION TOMOGRAPHY IN HEPATOCELLULAR CARCINOMAS. M. Wong1, M. H. Jamal1, P. Chaudhury1, T. T. Tran1, E. Simoneau1, S. Jabbour1, Y. Yousef1, Y. Jozaghi1, S. Al-Abbad1, M. Al-Jiffry1, J. Kwan1, G. Arena1, P. Metrakos1, M. Hassanian1; 1McGill University Health Centre, Montreal, QC



Oral Poster I Liver II Continued

OP-A5.07 IL-10 AND PD1 MEDIATE T CELL SUPPRESSION IN JAUNDICED ANIMALS WITH OPPOSING EFFECTS ON INFLAMMATORY CYTOKINE PRODUCTIONL. A. Licata1, C. Nguyen 1, S. Naheed1, N. J. Espat1, S. Katz1,2; 1Roger Williams Medical Center, Providence, RI; 2Boston University, Boston, MA

OP-A5.08 SORAFENIB INDUCED VASCULATURE CHANGES IMPROVES SURVIVAL WHEN COMBINED WITH YTTRIUM-90 RADIO-EMBOLIZATION FOR THE TREATMENT OF ADVANCED HCCA. Salman1, L. Boucher1, M. Hassanain1, E. Simoneau1, M. Jamal1, M. Al-Jiffry1, C. Nudo1, P. Chaudhury1, J. Tchervenkov1, P. Metrakos1; 1McGill University Health Centre, Montreal, QC

OP-A5.09 THE ROLE OF PROPROTEIN CONVERTASES IN COLON CANCER PROGRESSIONJ. Kwan1, C. Benay1, D. Antonatos1, E. Simoneau1, M. Jamal1, M. Hassanain1, P. Metrakos1; 1McGill University Health Centre, Montreal, QC

OP-A5.10 MULTICENTER RESULTS OF STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR SECONDARY TUMORS OF THE LIVER.J. Sanabria1, B. Berber1, M. Yao2, K. Goodman4, M. MIlano3, A. Katz3, K. Stephans5, F. Aucejo5, J. Fung5; 1Department Of Surgery, University Hospitals Case Medical Center, Cleveland, OH; 2Department Of Radiation Oncology, University Hospitals Case Medical Center, Cleveland, OH; 3Department Of Radiation Oncology, University Of Rochester Medical Center, Rochester, NY; 4Department Of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY; 5Department Of Surgery, Cleveland Clinic, Cleveland, OH

Oral Poster I Pancreas IIModerator: Aaron Sasson

OP-A6.01 COMBINED PANCREATICODUODENECTOMY AND COLON RESECTION FOR LOCALLY ADVANCED TUMORS OF THE PANCREATIC HEAD: ANALYSIS OF POST-OPERATIVE MORBIDITY AND MORTALITY.S. J. Temple1, P. T. Kim1, S. P. Cleary1, I. D. McGilvray1, S. Gallinger1, A. C. Wei1; 1Department Of Surgery, Toronto, ON

OP-A6.02 ADENOCARCINOMA ARISING IN INDRADUCTAL PAPILLARY MUCINOUS NEOPLSMS (IPMN): A DIFFERENT BIOLOGICAL PROFILE AND CLINICAL OUTCOMEG. Morris-Stiff1, G. A. Falk1, S. Chalikonda1, R. M. Walsh1; 1Department Of General Surgery, Section Of Surgical Oncology/HPB, Cleveland, OH

OP-A6.03 LAPAROSCOPIC TRANSGASTRIC ENDOLUMENAL CYSTGASTROSTOMY AND PANCREATIC DEBRIDEMENTK. A. Simo1, R. Z. Swan1, D. Sindram1, J. B. Martinie1, D. A. Iannitti1; 1Section Of Hepatobiliary And Pancreatic Surgery, Dept. General Surgery, Carolinas Medical Center, Charlotte, NC

OP-A6.04 TUMOR LOCATION IN PANCREATIC CANCER INFLUENCES LYMPH NODE POSTIVITYV. Siripurapu1, E. Liu1, A. Khithani1, A. Mejia1, R. Dickerman1, D. R. Jeyarajah1; 1Methodist Dallas Medical Center, Dallas, TX

OP-A6.05 PRE AND INTRAOPERATIVE VARIABLES AFFECTING EARLY OUTCOMES IN ELDERLY PATIENTS UNDERGOING PANCREATICODUODENECTOMYS. G. De La Fuente1, K. M. Bennett2, T. N. Pappas2, J. E. Scarborough2; 1H. Lee Moffitt Cancer Center, Tampa, FL; 2Duke University Medical Center, Durham, NC

OP-A6.06 ROBOTIC-ASSISTED DISTAL PANCREATECTOMY IS SAFE AND FEASIBLE.P. Suman1,2, J. Rutledge1, A. Yiengpruksawan1; 1The Daniel And Gloria Blumenthal Cancer Center, The Valley Hospital, Paramus, NJ; 2Department Of Surgery, Harlem Hospital Center, New York, NY

OP-A6.07 PANCREATIC FISTULA AFTER RESECTION OF PANCREATIC DUCTAL ADENOCARCINOMA DOES NOT ADVERSELY AFFECT DISEASE FREE SURVIVALR. M. Cannon1, G. G. Callender1, K. M. McMasters1, C. R. Scoggins1; 1University Of Louisville Department Of Surgery Division Of Surgical Oncology, Louisville, KY

Continued next page



Oral Poster I Pancreas III Continued

OP-A6.08 VALUE OF INTRA-OPERATIVE ULTRASOUND FOR THE PERFORMANCE OF PANCREATIC SURGERY: A MULTIDISCIPLINARY ASSESSMENTJ. Ni Mhuircheartaigh1, M. Sun1, N. Sanchez1, M. Callery1, B. Siewert1, C. Vollmer2, R. Kane1; 1Beth Israel Deaconess Medical Center, Boston, MA; 2Hospital Of The University Of Pennsylvania, Philadelphia, PA

OP-A6.09 SIMULTANEOUS PANCREATECTOMY AND COLECTOMY: A SAFE COMBINATION?M. G. House1, M. Kilbane1, E. P. Ceppa1, A. Nakeeb1, T. J. Howard1, C. M. Schmidt1, N. J. Zyromski1, K. D. Lillemoe1, H. A. Pitt1; 1Department Of Surgery, Indianapolis, IN

OP-A6.10 THE KIND AND INFLUENCE OF THE DRAIN INFECTION UPON THE SEVERITY OF POST OPERATIVE PANCREATIC FISTULAK. Watanabe1, M. Taniguchi1, T. Einama1, K. Imai1, H. Karasaki1, T. Kono1, H. Furukawa1; 1Division Of Gastroenterological And General Surgery, Asahikawa Medical University, Asahikawa City, Hokkaido

Oral Poster I Pancreas IIIModerator: Aram Demirjian

OP-A7.01 RENAL CELL CARCINOMA METASTASES TO THE PANCREAS: A WORTHWHILE INDICATION FOR RESESCTIONK. E. Westesson2, G. A. Falk1, G. Morris-Stiff1, C. H. Simpfendorfer1, S. Chalikonda1, M. C. Gong2, S. C. Cambpell2, R. M. Walsh1; 1Cleveland Clinic Foundation, Cleveland, OH; 2Cleveland Clinic Foundation, Cleveland, OH

OP-A7.02 A SURGEONS LEARNING EXPERIENCE OF PANCREATICODUODENECTOMIES(PD): IT CONTINUES DESPITE A DECADE LONG EXPERIENCEV. Siripurapu1, E. Liu1, A. Khithani1, T. Winston1, D. R. Jeyarajah1; 1Methodist Dallas Medical Center, Dallas, TX

OP-A7.03 CASE SERIES AND LITERATURE REVIEW OF PANCREATIC ACINAR CELL CYSTADENOMAA. M. Wolf1, C. J. Yeo1, J. Winter1, A. J. Prestipino2, H. Lavu1; 1Department Of Surgery, Thomas Jefferson University, Philadelphia, PA; 2Department Of Pathology, Thomas Jefferson University, Philadelphia, PA

OP-A7.04 TOTAL LAPAROSCOPIC PANCREATICODUODENECTOMY: EARLY SINGLE INSTITUTION EXPERIENCEA. Kamyab1, K. Khatlani1, M. J. Jacobs1; 1Providence Hospital And Medical Centers, Southfield, MI

OP-A7.05 IMPACT OF ABERRANT RIGHT HEPATIC ARTERY ON ONCOLOGIC MARGINS AND OUTCOMES AFTER PANCREATICODUODENECTOMYP. T. Kim1, S. Temple1, I. D. McGilvray1, S. Gallinger1, P. D. Greig1, A. C. Wei1; 1Toronto General Hospital, Toronto, ON

OP-A7.06 MAJOR PANCREATIC RESECTIONS CAN SAFELY BE PERFORMED AT A COMMUNITY HOSPITAL.P. Suman1,2, J. Rutledge1, S. Rajayer2, A. Yiengpruksawan1; 1The Daniel And Gloria Blumenthal Cancer Center, The Valley Hospital, Paramus, NJ; 2Department Of Surgery, Harlem Hospital Center, New York, NY

OP-A7.07 LYMPHOEPITHELIAL CYSTS OF THE PANCREAS: A MANAGEMENT DILEMMAJ. Martin2, J. K. Roberts2, G. Morris-Stiff2, G. A. Falk1, D. Joyce1, M. Sheridan3, R. M. Walsh1, A. M. Smith2; 1Department Of General Surgery, Section Of Surgical Oncology/HPB, Cleveland, Ohio; 2Department Of Pancreatic Surgery, Leeds, West Yorkshire; 3Department Of Radiology, Leeds, West Yorkshire

OP-A7.08 COMPARISON OF STANDARD DISTAL PANCREATECTOMY AND SPLENECTOMY TO RADICAL ANTEGRADE MODULAR PANCREATOSPLENECTOMYP. Trottman1, K. Swett1, P. Shen1; 1Wake Forest University School Of Medicine, Department Of General Surgery, Winston Salem, NC


FRIDAY5:30 – 6:30 pm Special Symposium: The Cutting edge

Moderators: Alan Koffron & Felipe Coimbra

Split in Situ: A Modern Approach for Avoiding Postoperative Liver Failure – Eduardo de Santibañes

Forging Frontiers in Liver Surgery – Peter Lodge

Biodegradable Stents in Benign Biliary Anastomotic Strictures – Mariano Gimenez

Invited Video: Robotic Hepatectomy – Al Hemming

5:30 – 7:00 pM TriCkS of The TraDe: Technical pearls of your CraftRoom: Ocean Tower I A-C Moderators: Rob Glasgow & Margo Shoup

ToT.01 SMA FIRST DISSECTION TO FACILITATE VENOUS RESECTION DURING PANCREATICODUODENECTOMYD. Bourgeois1, D. Schuitevorder1, J. Bolton1, W. Conway1; 1Ochsner Medical Center, New Orleans, LA

ToT.02 A SAFE LAPARSCOPIC APPROACH TO LEFT PORTAL PEDICLE CONTROL: LIGAMENTUM VENOSUM TECHNIQUEK. Enestvedt2, I. Gur1, K. G. Billingsley1; 1Oregon Health And Science University, Portland, OR; 2University Of Pennsylvania Health System, Philadelphia, PA

ToT.03 TEMPORARY PORTO-CAVAL SHUNTING IN ORTHOTOPIC LIVER TRANSPLANTATION: IS THIS TECHNIQUE THE ANSWER TO BLEEDING AND EXPOSURE?S. N. Nadig1, P. G. Alluri1, D. D. Lee1, S. J. Pelletier1; 1University Of Michigan Health System, Ann Arbor, MI

ToT.04 THE USE OF HYDROGEN PEROXIDE TO IDENTIFY SMALL BILE LEAKS DURING LIVER RESECTION.A. Zarrinpar1, M. Rajan1, F. M. Kaldas1, R. W. Busuttil1; 1Dumont-UCLA Transplant Center, Los Angeles, CA

ToT.05 A NOVEL TECHNIQUE FOR LAPAROSCOPIC PANCREATICOJEJUNOSTOMYB. T. Neichoy1, J. G. Trevino1, K. E. Behrns1, S. J. Hughes1; 1University Of Florida - Department Of Surgery, Gainesville, FL

ToT.06 COMMON BILE DUCT EXPLORATION VIA CYSTIC DUCT WITH A SPECIAL REFERENCE TO SEPTUM-LIKE STRUCTURE AT THE JUNCTION: A SURGICAL PEARL TO AVOID BILE DUCT STRICTUREA. Shimizu1, M. Hyodo1, Y. Sakuma1, T. Fujiwara1, H. Sasanuma1, M. Koizumi1, N. Sata1, Y. Yasuda1; 1Department Of Surgery, Jichi Medical University, Shimotsuke, Tochigi

ToT.07 USE OF HD VIDEO MICROSCOPY IN THE LOCAL RESECTION OF PANCREATIC HEAD AND AMPULLARY TUMORSN. N. Nissen1, V. Menon1, J. Williams1, G. Berci1; 1Cedars-Sinai Medical Center, Los Angeles, CA

ToT.08 INTERCOSTAL AND TRANS-THORACIC TROCARS FACILITATE LAPAROSCOPIC RESECTION OF HIGH POSTERIOR LESIONS OF THE LIVER.N. O’Rourke1; 1Royal Brisbane Hospital, Brisbane, Q

ToT.09 SKELTONIZATION NOT RESECTION OF THE SUPERIOR MESENTERIC VEIN IN PDRM. G. Wayne1, J. G. Steele1, A. M. Cooperman1; 1Pancreas And Biliary Center Of New York At Beth Israel Medical Center, New York, NY

ToT.10 SURGERY FOR LIVER MALIGNANCIES WITH TUMOR THROMBUS EXTENDING INTO THE SUPRA-DIAPHRAGMATIC INFERIOR VENA CAVA AND RIGHT ATRIUM WITHOUT THE USE OF CARDIOPULMONARY BYPASSE. Vicente1, Y. Quijano1, H. Duran1, E. Diaz1, I. Fabra1, R. Puga1; 1Madrid Sanchinarro University Hospital. “Clara Campal” Oncological Center. San Pablo University., Madrid, MADRID


FRIDAY5:30 – 7:00 pm Tricks of the Trade: Technical pearls of your Craft Continued

ToT.11 SCARLESS HEPATECTOMY - NATURAL ORIFICE SPECIMEN EXTRACTION AFTER LEFT LATERAL SECTIONECTOMY.I. R. Orso1, P. Herman2, H. M. Matsumoto1, C. A. Carvalho1, M. W. Bonatto1, T. M. Tanaka1, U. E. Sagae1; 1Gastroclinica Cascavel, Parana Brazil 2University Of Sao Paulo School Of Medicine, Sao Paulo, Sao Paulo, Brazil

ToT.12 THREE-DIMENSIONAL (3-D) CT VIRTUAL SIMULATION AND SURGICAL PLANNING FOR MINIMALLY INVASIVE HEPATIC RESECTIONA. V. Maker1,3, V. K. Maker2,3; 1University Of Illinois At Chicago, Department Of Surgery, Division Of Surgical Oncology, Chicago, IL; 2University Of Illinois At Chicago, Department Of Surgery, Chicago, IL; 3Creticos Cancer Center At Advocate Illinois Masonic Medical Center, Chicago, IL

6:45 - 10:00 pM eVening SoCial eVenTS

6:45 - 7:30 pm Cocktail Reception in the Exhibit Hall Room: Pompeii

Hors d’oeuvres and Drinks Served

7:30 -10:00 pm 2012 AHPBA Banquet Outside in the Ocean Garden

Join us for dinner, drinks, a live band and more. Plus, a few special announcements


SATURDAY6:15 - 7:30 aM eThiCon enDo-Surgery inDuSTry SponSoreD

BreakfaST SyMpoSiuM (no CME credits provided)

Breakfast provided by AHPBA

Minimally Invasive Pancreatico-Duodenectomy: Building a Sustainable PracticeRoom: Ocean Tower II ABFaculty: Sricharan Chalikonda, Kevin T. Watkins

key points include:•Initialconsiderationsandstepspriortofirstcase•Tipsonbuildingateam•Bestpracticesandkeylearnings•Sustaininghospitalsupport-identifyingthedifferencesindisposablesforopenandminimally

invasive techniques•Planstoimproveforthefuture

6:30 am - 5:00 pm Reistration DeskLocation: Ocean Tower 1 Foyer

7:00 - 8:00 am Breakfast in the Exhibit Hall Room: Promenade & Pompeii

Exhibit Hall remains open until 12:00 pm

7:30 - 9:30 aM oral aBSTraCTS wiTh eMBeDDeD inViTeD ViDeo

7:30 - 9:30 am 8:00 - 9:30 am 8:00 - 9:30 am

Transplant/BiliaryRoom: Ocean Tower I CModerators: Xabier de Aretxabala & Majella DoyleVideo: Islet Transplant – Ernesto Molmenti

Liver IRoom: Ocean Tower I A/BModerators: Kevin Stavely-O’Carroll & Paulo Herman

Video: Hilar Cholangiocarcinoma: The No-touch Technique – Daniel Cherqui

Pancreas IRoom: Ocean Tower II CModerators: JR Delpero & William Hawkins

Video: Laparoscopic Portal Vein Resection – Mike Kendrick

7:30 - 9:30 am Transplant/BiliaryRoom: Ocean Tower I CModerators: Xabier de Aretxabala & Majella Doyle

O1-C.01 CONCOMITANT DYSREGULATION OF MIR-151-3P AND MIR-126 CORRELATES WITH IMPROVED SURVIVAL IN RESECTED CHOLANGIOCARCINOMAM. E. McNally1, A. Collins1, S. Wojcik1, J. Liu1, J. Henry1, J. Jiang1, T. Schmittgen1, M. Bloomston1; 1The Ohio State University Medical Center, Columbus, OH Discussant: Shishir Maithel

Continued next page


SATURDAY7:30 - 9:30 aM oral aBSTraCTS wiTh eMBeDDeD inViTeD ViDeo Continued

7:30 - 9:30 am Transplant/Biliary Room: Ocean Tower I C Continued

O1-C.02 A MULTI-INSTITUTIONAL STUDY OF THE PROGNOSTIC IMPORTANCE OF LYMPHOVASCULAR OR PERINEURAL INVASION IN INTRAHEPATIC CHOLANGIOCARCINOMA: A NEW SELECTION CRITERION FOR ADJUVANT THERAPY?S. B. Fisher1, S. H. Patel1, D. A. Kooby1, S. M. Weber2, M. Bloomston3, C. S. Cho2, I. Hatzaras3, C. Schmidt3, E. Winslow2, C. A. Staley1, S. K. Maithel1; 1Emory University, Division Of Surgical Oncology, Winship Cancer Institute, Atlanta, GA; 2University Of Wisconsin, Section Of Surgical Oncology, Madison, WI; 3The Ohio State University Medical Center, Division Of Surgical Oncology, Columbus, OH Discussant: Jim Pingpank

O1-C.03 IS DONATION AFTER CARDIAC DEATH DONOR LIVER TRANSPLANTATION STILL COST-EFFECTIVE OR JUST A MEANS OF SHIFTING WAIT-LIST DEATH TO RECIPIENT DEATH?L. A. Redhage1, D. E. Moore1; 1Vanderbilt University Medical Center, Nashville, TN Discussant: Paul Greig

Invited Video Presentation: Islet Transplant – Ernesto Molmenti

O1-C.04 TRANSHEPATIC-TRANSANASTOMOTIC STENTS IN BILE DUCT INJURY REPAIR: AN ANSWERED DILEMMA M. Mercado1, B. Franssen1, C. Chan1, R. Aramburo1, M. Mercado1; 1Department Of Surgery, Instituto Nacional De La Nutricion “Salvador Zubiran,” Mexico City, Mexico Discussant: Craig Fischer

O1-C.05 RECOGNITION OF WEAK SIGNALS MAY FACILITATE THE DETECTION AND PREVENTION OF LAPAROSCOPIC BILE DUCT INJURIES. A MULTIVARIATE HUMAN FACTORS ANALYSISL. Stewart1,2, C. O. Dominguez, 3, J. G. Hunter4, L. W. Way1; 1University Of CA, San Francisco, San Francisco, CA; 2SF VAMC, San Francisco, CA; 3Klein Associates, ARA, Exeter, NH; 4Oregon Health & Science University, Portland, ORDiscussant: Robert Glasgow

O1-C.06 DOES RADICAL RESECTION CURE INCIDENTAL GALLBLADDER CANCER? A CRITICAL VIEW.J. Lendoire1, L. P. Gil1, G. A. Raffin1, F. Duek1, C. M. Quarin1, V. B. Garay1, M. Rivaldi1, O. C. Imventarza1; 1Hospital Cosme Argerich, Liver And Transplant Division, Buenos Aires, Buenos Aires ArgentinaDiscussant: William Jarnagin

O1-C.07 OBESITY PORTENDS AN INCREASED MORBIDITY, ABBREVIATED SURVIVAL AND EARLY RECURRENCE FOLLOWING OLT FOR HEPATOCELLULAR CARCINOMAA. Mathur1, J. P. Leone1,3, E. S. Franco1,3, H. Osman-Mohamed1,3, H. Rojas3, N. Kemmer4, G. W. Neff2, A. S. Rosemurgy5, A. E. Alsina1,3; 1Department Of Surgery, University Of South Florida, Tampa, FL; 2Department Of Hepatology, Tampa General Hospital, Tampa, FL; 3Transplantation And Transplant Surgery, Tampa General Hospital, Tampa, FL; 4Department Of Digestive Disease, University Of Cincinnati, Cincinnati, OH; 5Tampa General Hospital, Tampa, FLDiscussant: Shimul Shah

8:00 - 9:30 am Long Oral I-A - Liver IRoom: Ocean Tower I A/BModerators: Kevin Stavely-O’Carroll & Paulo Herman

O1-A.01 RADIOFREQUENCY ABLATION VS. RESECTION FOR EARLY STAGE HEPATOCELLULAR CANCER: OUTCOMES FROM A WESTERN CENTERS. Tohme1, J. Cardinal2, R. Srinevas2, J. Steel2,3, J. W. Marsh2, D. A. Geller2, A. Tsung2; 1University Of Pittsburgh, Department Of Surgery, Pittsburgh, PA; 2Division Of Hepatobiliary And Pancreatic Surgery, Department Of Surgery, University Of Pittsburg, Pittsburgh, PA; 3Department Of Psychiatry, University Of Pittsburgh Medical Center, Pittsburgh, PADiscussant: Robert Martin



8:00 - 9:30 am Long Oral I-A - Liver I Room: Ocean Tower I A/B Continued

O1-A.02 SORAFENIB ABROGATES THE EXPANSION OF LIVER CD8+ REGULATORY T CELLS FOLLOWING PARTIAL HEPATECTOMYP. C. Kurniali1,2, C. Nguyen1, L. Licata1, V. Falanga1,2, N. J. Espat1,2, S. C. Katz1,2; 1Roger Williams Medical Center, Providence, RI; 2Boston University School Of Medicine, Boston, MADiscussant: Todd Bauer

Invited Video Presentation: Hilar Cholangiocarcinoma: The No-Touch Technique – Daniel Cherqui

O1-A.03 STAGED LIVER RESECTIONS FOR BILOBAR HEPATIC COLORECTAL METASTASIS: A SINGLE CENTER EXPERIENCEM. H. Jamal1, M. Hassanain1, P. Chaudhury1, Y. Yousef1, S. Wong 1, T. T. Tran1, Y. Jozaghi1, S. Jabbour1, A. Salman1, E. Simoneau1, J. Kwan1, S. Al-Abbad1, M. Al-Jiffry1, G. Arena1, A. Neville1, P. Metrakos1; 1McGill University Health Center, Montreal, QC CanadaDiscussant: Eduardo De Santibañes

O1-A.04 ADJUVANT ABLATION OF NEUROENDOCRINE METASTASES TO THE LIVER COMPLEMENTS SURGICAL RESECTIONT. Taner1, T. D. Atwell1, L. Zhang1, W. S. Harmsen1, M. L. Kendrick1, D. M. Nagorney1, F. G. Que1; 1Mayo Clinic, Rochester, MNDiscussant: Tim Pawlik

O1-A.05 SEQUENTIAL INTRA-ARTERIAL THERAPY AND PORTAL VEIN EMBOLIZATION IS FEASIBLE AND SAFE IN PATIENTS WITH ADVANCED PRIMARY AND SECONDARY LIVER MALIGNANCIESP. D. Peng1, C. Pulitano5, F. Shen6, M. Bloomston3, E. Dixon2, L. Aldrighetti5, B. Edil1, J. H. Geschwind1, K. Hirose1, C. L. Wolfgang1, R. D. Schulick1, M. A. Choti1, T. M. Pawlik1; 1Johns Hopkins Hospital, Baltimore, MD; 2University Of Calgary, Calgary, AB; 3Ohio State University, Columbus, OH; 4Curry Cabral Hospital, Lisbon, Lisboa; 5Liver Unit, Scientific Institute San Raffaele, Milan, Italy; 6Eastern Hepatobiliary Surgery Hospital, Shanghai, ChinaDiscussant: Felipe Coimbra

8:00 - 9:30 am Long Oral I-B - Pancreas IRoom: Ocean Tower II CModerators: JR Delpero & William Hawkins

O1-B.01 DISSECTING SURVIVAL FOR RESECTED PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) IN THE CONTEMPORARY ERAR. S. Lewis1, J. A. Drebin1, M. P. Callery2, D. L. Fraker1, T. S. Kent2, J. L. Gates1, C. M. Vollmer1; 1The University Of Pennsylvania School Of Medicine, Philadelphia, PA; 2Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MADiscussant: Thomas Howard

O1-B.02 FAILURE TO COMPLY WITH NCCN GUIDELINES FOR MANAGEMENT OF PANCREATIC CANCER COMPROMISES OUTCOMES.B. C. Visser1,2, Y. Ma2, Y. Zak1, K. Rhoads1,2; 1Stanford University Department Of Surgery, Stanford, CA; 2Stanford Cancer Institute, Stanford, CADiscussant: Mark Callery

O1-B.03 CELLULAR ATYPIA IN PANCREATIC CYST CYTOLOGY ASSESSMENTS: SURGERY IS OFTEN REQUIREDG. A. Falk1, G. Morris-Stiff1, S. Chalikonda1, C. Biscotti2, R. M. Walsh1; 1Department Of General Surgery, Section Of Surgical Oncology/HPB, Cleveland, OH; 2Department Of Cytopathology, Cleveland, OHDiscussant: Charles Vollmer

Continued next page



8:00 - 9:30 am Long Oral I-B - Pancreas I Room: Ocean Tower II C Continued

Invited Video Presentation: Laparoscopic Portal Vein Resection – Michael Kendrick

O1-B.04 JAUNDICE, AN IMPORTANT UNRECOGNIZED RISK FACTOR FOR POOR LONG TERM SURVIVAL IN PATIENTS WITH ADENOCARCINOMA OF THE HEAD OF THE PANCREASS. M. Strasberg1, D. C. Linehan1, W. G. Hawkins1, F. Gao1; 1Washington University In St Louis And Barnes-Jewish Hospital, St Louis, MODiscussant: Michael Farnell

O1-B.05 POST-RESECTION DIABETES AFTER PANCREATICODUODENECTOMY: INCIDENCE AND PREDICTIVE FACTORS M. J. Ferrara1, C. M. Lohse1, M. B. Farnell1, F. G. Que1, K. M. Reid-Lombardo1, J. H. Donohue1, D. M. Nagorney1, S. S. Vege1, S. T. Chari1, M. L. Kendrick1; 1Mayo Clinic, Rochester, MN Discussant: John Christein

9:30 - 10:00 aM parallel STaTe-of-The-arT leCTureS

The Necrotic Pancreas Room: Ocean Tower II A/B Introduction: Nick Zyromski Speaker: Ross Carter

Regionalization of HPB Surgery: 10 Years On Room: Ocean Tower I A/B Introduction: Jeff Barkun Speaker: Elijah Dixon

10:00 am Coffee Break – Location: Ocean Tower I Foyer

10:15 - 11:00 aM DeBaTe

What is the Best Order of Chemotherapy for Colorectal Metastases? Room: Ocean Tower I A-CModerators: Bryan Clary & Christina Ferrone

Before Resection – Tom Aloia Delayed Resection – Michael D’Angelica

11:00 am - 12:30 pm Symposium – great problems of our Time Room: Ocean Tower I A-CModerators: Richard Schulick & Sharon Weber

TransplantSpeaker – Shimul ShahSenior Perspective – Javier Lendoire

LiverSpeaker – Michael HouseSenior Perspective – James Garden

Biliary Speaker – Shishir MaithelSenior Perspective – Steven Strasberg

PancreasSpeaker – John AllendorfSenior Perspective – Andy Lowy


SATURDAY11:00 aM – 12:30 pM SeQuenTial upDaTe leCTureS

11:00 am – 11:45 am French Cooperative Experience with Pancreatic Cancer Room: Ocean Tower II A/B Introduction: Todd Bauer Speaker: JR Delpero Rebutal / Opinion: Howard Reber

11:45 am – 12:30 pm Islet Cell Transplantation Room: Ocean Tower II A/B Introduction: Syed Ahmad Speaker: John Christein Rebutal/Opinion: Jeff Mathews

12:30 – 2:00 pM parallel lunCh eVenTS

lunch with The professors

Bring Your Own Pancreas Cases to the ProfessorsDavid Adams & Brett SheppardRoom: LaGorce

Bring Your Own Liver Cases to the ProfessorsJames Garden & Reid AdamsRoom: Palm

Multidisciplinary HPB ApproachesScott Helton, Peter Cotton & Alessandro DinizRoom: Bay Shore

MIS Pancreatic Resection for Malignant TumorsLaureano Fernandez-Cruz & Herb ZehRoom: San Marino

ahpBa accredited Satellite Symposium (This is a CME Accreditation educational activity for a maximum of 1.5 AMA PRA Category I Credits)Lunch provided by the AHPBA .Room: Ocean Tower II A/B

Supported by AngioDynamics

irreversible electroporation: emerging Treatment Modality for Borderline and locally advanced pancreatic Cancer

overview: Irreversible electroporation (IRE) is a novel ablation modality that uses low-energy electrical pulses to permanently open the pores in cell membranes, which leads to cell death in the target tissue. Because it does not rely on heat to create the ablation, IRE is the first focal ablative modality with the potential to ablate soft tissue near critical structures, such as vessels and ducts.

The goal of this symposium is to educate participants on this emerging ablation modality, including the safety, initial clinical experience, and outcomes in the treatment of borderline and locally advanced pancreatic cancer.

Continued next page


SATURDAY12:30 – 2:00 pM parallel lunCh eVenTS Continued

AHPBA Accredited Satellite Symposium Room: Ocean Tower II A/B Continued

Introduction, Program Overview, Proof of Concept – Robert Martin

Initial Experience and Outcomes of IRE in Locally Advanced Pancreatic Adenocarcinoma – Kevin Watkins

Use Of Irreversible Electroporation (IRE) for Margin Accentuation in Resectable Pancreatic Cancer: Experience at The Cleveland Clinic – Sricharan Chalikonda

Establishing an Ire Program in a Community Setting – Eric Kortz

Irreversible Electroporation (IRE) in Locally Advanced Pancreatic Cancer: Multi-Institutional Evaluation and Planned Initiation of Phase II Clinical Trials – Robert Martin

Question & Answer – Faculty

2:00 - 2:05 pm IHPBA World Congress Meeting UpdateJacques BelghitiRoom: Ocean Tower 1 A-C

2:05 - 2:30 pm IHPBA Presidential Address: C. Wright Pinson, MD, MBA Room: Ocean Tower I A-C

2:30 - 3:00 pM parallel STaTe-of-The-arT leCTureS

Margins in Pancreatic Cancer Surgery Room: Ocean Tower I A-C Introduction: Matthew Katz Speaker: Caroline Verbeke

Living Donor Liver Surgery Today Room: Ocean Tower II A/B Introduction: Jean Emond Speaker: Paul Greig

3:00 – 4:30 pm Symposium – hpB Training – which path is better? Room: Ocean Tower II A/BModerators: Rebecca Minter & John Martinie

The SSO Perspective – Clark Gamblin

The HPB Perspective – Adnan Alseidi

South American Perspective – Johnny Hong

Format for training HPB Surgeons in South America – Lucas McCormack

3:00 – 5:00 pm Technical Toolbox Series: The whipple operationSession Co-sponsored by the Pancreas Club Room: Ocean Tower I A-C Moderators: Tom Howard & Peter Allen

Master Surgeon Panelists Michael Farnell, Charles Yeo and Alex Rosemurgy

The Patient is 83. Assessment and Management of the Elderly – Kimberly Kirkwood

I’ve Got a Case to Follow (Creating Efficiency) – Carlos Chan

Holy #@%.....There’s Blood Everywhere! – Chad Ball

The Tumor is Stuck to the Vein, Now What? – Craig Fischer

Should I Place a J-tube? – Steve Behrman

The Anastomosis Fell Apart – Nipun Merchant


SATURDAY4:30 – 5:00 pM STaTe-of-The-arT leCTure

Video-Based HPB Education Room: Ocean Tower II A/B Introduction: Craig Fischer Speaker: Horacio Asbun

5:00 – 5:45 pM upDaTe leCTure

The Borderline Resectability Concept Room: Ocean Tower I A-C Introduction: Jim Moser Speaker: Jason Fleming Rebutal / Opinion: Mark Talamonti

5:30 – 7:00 pM oral poSTer iiRoom: Promenade

5:30 – 7:00 pm Oral Poster II Pancreas AModerator: Harish Lavu

Moved to OP-A3.08 See page 33OP-B1.01 RISK FACTORS FOR DELAYED GASTRIC EMPTYING AFTER PANCREATICODUODENECTOMYV. M. Thumma1, N. Bheerappa1, R. A. Sastry1; 1Nizam’s Institute Of Medical Sciences, Hyderabad, Ap

OP-B1.02 NEUTROPHIL TO LYMPHOCYTE RATIO: PREDICTOR OF POOR OUTCOME IN ACUTE PANCREATITISA. Suppiah1, D. J. Malde1, T. Arab1, A. M. Smith1, G. Morris-Stiff1; 1The HPB Unit, Leeds, Yorshire

OP-B1.03 EXPLORATION OF ENHANCING PANCREATIC CANCER TARGETED COMBINATION THERAPY THROUGH ANTIENDOTHELIAL EMAP IIN. Awasthi1, W. Ruan1, C. Zhang1, M. A. Schwarz2, R. E. Schwarz1; 1University Of Texas Southwestern Medical Center, Dallas, TX; 2University Of Texas Southwestern Medical Center, Dallas, TX

OP-B1.04 THE PREVALENCE AND SIGNIFICANCE OF EXTRAPANCREATIC CYSTS IN PATIENTS WITH PANCREATIC CYSTIC LESIONSM. J. Weiss1, S. Gaujoux1, E. C. Zabor1, M. Gonen1, M. Schattner1, M. I. D’Angelica1, Y. Fong1, T. P. Kingham1, R. P. DeMatteo1, W. R. Jarnagin1, P. J. Allen1; 1Memorial Sloan-Kettering Cancer Center, New York, NY

OP-B1.05 SUPERIOR MESENTERIC VEIN (SMV) MARGIN POSITIVITY IN RESECTABLE PANCREATIC CANCER CORRELATES WITH HIGH SUEPERIOR MESENTERIC ARTERY (SMA) MARGIN POSITIVITY; IS VEIN RESECTION ADVISIBLE?V. Siripurapu1, E. Liu1, A. Khithani1, T. Winston1, D. R. Jeyarajah1; 1Methodist Dallas Medical Center, Dallas, TX

OP-B1.06 REFERRAL PATTERNS IN PANCREATIC CANCER TO A HIGH VOLUME CENTER; THE GASTROENETEROLOGIST REMAINS YOUR FRIENDV. Siripurapu1, T. Winston1, E. Liu1, D. R. Jeyarajah1; 1Methodist Dallas Medical Center, Dallas, TX

OP-B1.07 HOW DOES LAPAROSCOPIC ASSISTED PANCREATICODUODECTOMY COMPARE TO THE CONVENTIONAL OPEN SURGICAL APPROACH?J. A. Graham1, J. Smirniotopoulos1, J. Nusbaum1, L. B. Johnson1; 1Department Of Surgery, Georgetown University Hospital, Washington, DC

OP-B1.08 RETROSPECTIVE COMPARISON OF MINIMALLY INVASIVE VERSUS OPEN PANCREATICODUODENECTOMY FOR PERIAMPULLARY NEOPLASMSP. Q. Bao1, P. Mazirka1, K. T. Watkins1; 1Stony Brook University Medical Center, Stony Brook, NY


SATURDAY5:30 – 7:00 pM oral poSTer ii Room: Promenade Continued

Oral Poster II Liver AModerator: Carlos Covera

OP-B2.01 PKI-587 IN COMBINATION WITH SORAFENIB SYNERGISTICALLY INHIBIT HCC CELL PROLIFERATIONR. Gedaly1, P. Angulo2, J. Hundley1, M. F. Daily1, C. Chen1, B. M. Evers1,3; 1Department Of Surgery, University Of Kentucky, Lexington, KY; 2Department Of Internal Medicine, University Of Kentucky, Lexington, KY; 3Markey Cancer Center, University Of Kentucky, Lexington, KY

OP-B2.02 - Withdrawn

OP-B2.03 A SYSTEMATIC REVIEW OF SURGICAL MANAGEMENT OF NEUROENDOCRINE LIVER METASTASESS. Y. Lee1,2, J. Y. Teo2, P. C. Cheow2, L. L. Ooi1,2; 1Department Of Surgical Oncology, National Cancer Centre, Singapore, Singapore; 2Department Of General Surgery, Singapore General Hospital, Singapore, Singapore

OP-B2.04 EXPERIENCE WITH SELECTIVE TRANSARTERIAL EMBOLIZATION AS A THERAPEUTIC OPTION FOR FOCAL NODULAR HYPERPLASIA: A CASE SERIES.M. Zanini, RN, MSN, CNP1, A. Abou Abbass1, M. Kazimi1, A. Yoshida1, M. Abouljoud1; 1Henry Ford Hospital Division Of Transplant & Hepatobiliary Surgery, Detroit, MI

OP-B2.05 COMBINED RADIOFREQUENCY ABLATION AND RESECTION FOR METASTASIC COLORECTAL CANCER TO THE LIVERS. G. De La Fuente1, J. M. Weber1, T. J. Yeatman1, M. P. Malafa1, J. Choi1, D. Shibata1; 1H. Lee Moffitt Cancer Center, Department Of Gastrointestinal Oncology, Tampa, FL

OP-B2.06 SINGLE CENTER EXPERIENCE WITH IRREVERSIBLE ELECTROPORATION FOR LIVER AND PANCREAS TUMOR ABLATIONN. S. Ali1, S. Cohn1,2, V. Raofi1,2; 1Beaumont Health System, Royal Oak, MI; 2Oakland University William Beaumont School Of Medicine, Royal Oak, MI

OP-B2.07 PATIENT AND CLINICOPATHOLOGICAL FEATURES, AND PROGNOSIS OF CK19+ HEPATOCELLULAR CARCINOMAS: A CASE-CONTROL STUDYJ. Jang1, P. T. Kim2, P. D. Greig2, S. Gallinger2, C. Moulton2, A. C. Wei2, S. E. Fischer2, S. P. Cleary2; 1Faculty Of Medicine, University Of Toronto, Toronto, ONTARIO; 2Toronto General Hospital, Toronto, Ontario

OP-B2.08 CLINICAL PREDICTORS OF EPCAM OVER-EXPRESSION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA: AN EVALUATIONE. M. Dunki-Jacobs1, Y. Li1, C. R. Scoggins1, K. M. McMasters1, G. G. Callender1, R. C. Martin1; 1University Of Louisville, Louisville, KY

OP-B2.09 VOLUMETRIC ASSESSMENT OF SINGLE APPLICATION, SINGLE ANTENNA MICROWAVE ABLATION OF LIVER LESIONS ON CT IMAGINGD. Sindram1, E. M. Hanna1, K. A. Simo1, J. B. Martinie1, D. A. Iannitti1; 1Carolinas Medical Center - Dept. Of General Surgery, Div. Of Hepatobiliary And Pancreas Surgery, Charlotte, NC

OP-B2.10 PERIPHERAL BLOOD MYELOID CELL POPULATIONS EXPAND IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH RESECTION AND ABLATION, BUT NOT WITH ENDOLUMINAL THERAPYP. Newell1,2, B. Cottam2, T. Savage2, C. Hammill1, S. Cho1, M. Cassera1, R. Wolf1, T. Thiesing1, M. Gough2, P. Hansen1; 1Providence Portland Medical Center, Portland, OR; 2Earle A. Chiles Research Institute, Portland, OR



Oral Poster II Tricks of the Trade AModerator: Satish Nadig

OP-B3.01 CHOLEDOCHODUODENOSTOMY FOR BENIGN BILIARY STRICTUREA. Kamyab1, M. J. Jacobs1; 1Providence Hospital And Medical Centers, Southfield, MI

OP-B3.02 NEW TRICKS FOR AN OLD DOG: ACHIEVING HIGH ASSISTED PATENCY FOR PERITONEOVENOUS SHUNTSZ. P. Englert1, M. A. White1, R. K. Padia1, H. Chheda2, E. E. Zervos1; 1East Carolina University, Greenville, NC; 2University Of South Florida, Tampa, FL

OP-B3.03 CENTRAL PANCREATECTOMYA. Kamyab1, M. J. Jacobs1; 1Providence Hospital And Medical Centers, Southfield, MI

OP-B3.04 LAPAROSCOPIC MICROWAVE ABLATION OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH PORTAL HYPERTENSION; TECHNICAL TIPS FOR A SAFE PROCEDUREM. Vivanco1, E. Feinberg1, J. Chapochnick Friedmann1; 1Montefiore Medical Center / Albert Einstein College Of Medicine, Bronx, NY

OP-B3.05 AGGRESSIVE (SHOTGUN) APPROACH TO THE NONOPERATIVE MANAGEMENT OF SEVERE PANCREATIC DUCT DISRUPTIONA. Abdo1, N. Jani1, S. C. Cunningham1; 1Saint Agnes Hospital Center, Baltimore, MD

OP-B3.06 INTRAOPERATIVE ULTRASOUND GUIDED DISSECTION DURING THE WHIPPLE PROCEDUREI. Koleilat1, P. Parikh1, R. Chiu1, N. Zeinomar2, R. Petrov1, S. Stain1, A. Nigam1; 1Department Of Surgery, Albany Medical College, Albany, NY; 2Department Of Epidemiology & Biostatistics, School Of Public Health, University At Albany, SUNY, Rensselaer, NY

OP-B3.07 PANCREATIC ANASTOMOSIS IN THE SOFT PANCREAS AFTER PANCREATICODUODENAL RESECTIONW. G. Michael1, J. G. Steele1, A. M. Cooperman1; 1Pancreas And Biliary Center Of New York At Beth Israel Medical Center, New York, NY

OP-B3.08 MANAGEMENT OF THE DIFFICULT PANCREATIC STUMP AFTER PANCREATIC RESECTIONN. N. Nissen1, V. Menon1, A. Annamalai1; 1Cedars-Sinai Medical Center, Los Angeles, CA

Oral Poster II Tricks of the Trade BModerator: Barish Edil

OP-B4.01 HOW TO DO A WHIPPLE IN APPROXIMATELY THREE HOURS: SEPARATION OF THE RIGHT COLON MESENTERY TO FIND THE SMV AND THE CONCEPT OF THE MESOPANCREASV. Siripurapu1, D. R. Jeyarajah1; 1Methodist Dallas Medical Center, Dallas, TX

OP-B4.02 STOMACH PRESERVING DISTAL PANCREATECTOMY WITH CELIAC AXIS RESECTION: THE BENEFIT AND CHALLENGE OF A REPLACED RIGHT HEPATIC ARTERYO. Hamed1, N. Gusani1, J. Kaifi1, E. Kimchi1, K. Staveley-O’Carroll1; 1Section Of Surgical Oncology, Department Of Surgery, Penn State College Of Medicine, Hershey PA, Hershey, PA

OP-B4.03 TRANSTHORACIC TRANSDIAPHRAGMATIC VIDEOSCOPIC-ASSISTED MICROWAVE ABLATION (MWA) OF SMALL HCC IN SEGMENT VIIW. S. Helton1, R. Kohler1, M. Fotoohi1, A. Alseidi1, F. Rocha1, T. Biehl1; 1Virginia Mason Medical Center, Seattle, WA

OP-B4.04 HEPATIC ARTERIAL CLAMPING ALONE, RATHER THAN PORTAL TRIAD CLAMPING, CAN BE USED TO REDUCE PARENCHYMAL BLEEDING DURING LAPAROSCOPIC LIVER RESECTION.N. O’Rourke1; 1Royal Brisbane Hospital, Brisbane, Q

Continued next page



Oral Poster II Tricks of the Trade B Continued

OP-B4.05 LAPAROSCOPIC TRANSECTION OF THE THICK PANCREAS; A NON-STAPLER TECHNIQUEA. Alseidi1, F. Rocha1, S. Helton1; 1Virginia Mason Medical Center, Seattle, WA

OP-B4.06 EXTENDED RIGHT HEMIHEPATECTOMY AND LEFT METASTASECTOMY AFTER IN SITU SPLIT. A NEW SURGICAL STRATEGY PERFORMED IN TWO STAGES TO ACHIEVE RESECTABILITY OF BILOBAR LIVER METASTASESE. Vicente 1, Y. Quijano1, H. Duran1, E. Diaz1, I. Fabra1, R. Puga1; 1Madrid Sanchinarro University Hospital. “Clara Campal” Oncological Center. San Pablo University., Madrid

Oral Poster II Pancreas BModerator: Norberto Sanchez

Moved to OP-A1.08 See page 32OP-B5.01 107 PANCREATIC RESECTIONS : FACTORS AFFECTING MORTALITY AND MORBIDITYV. M. Thumma1, N. Bheerappa1, R. A. Sastry1; 1Nizam’s Institute Of Medical Sciences, Hyderabad

OP-B5.02 SURGICAL APPROACH IN PANCREATIC CANCER WITH PREOPERATIVE 3D-CT COMPUTER ASSISTED SURGERY PLANNINGY. Abe1, K. Takano1, M. Shimazu1; 1Department Of Surgery, Tokyo Medical University Hachioji Medical Center, Hachioji, Tokyo

OP-B5.03 COLORECTAL METASTASES TO THE PANCREAS: A SINGLE INSTITUTION EXPERIENCEL. C. Morley1, J. K. Roberts1, C. S. Verbeke2, G. Morris-Stiff1, A. M. Smith1; 1Department Of Pancreatic Surgery, Leeds, West Yorkshire; 2Department Of Histopathology, Leeds, West Yorkshire

OP-B5.04 IS THE TYPE OF POST-OPERATIVE PAIN CONTROL RELATED TO PANCREATIC FISTULA FORMATION AFTER OPEN DISTAL PANCREATECTOMY?H. H. Bach IV1, E. Pappano1, E. Bock1, M. Shoup1, G. Aranha1; 1Loyola University Medical Center, Maywood, IL

OP-B5.05 OUTCOMES OF PANCREATIC SURGERY: A RETROSPECTIVE ANALYSIS FROM A CANADIAN TERTIARY CARE CENTERK. M. Eltawil1, M. Molinari1, M. J. Walsh1; 1Department Of Surgery, Dalhousie University, Halifax, NS

OP-B5.06 VASCULAR RESECTION AND RECONSTRUCTION FOR A REPLACED RIGHT HEPATIC ARTERY CAN BE AVOIDED DURING A PANCREATICODUODENECTOMY PROCEDUREJ. M. Zakhary1, H. Shokouh-Amiri1, G. Zibari1,2, H. D’Agostino1, Q. D. Chu1; 1Lousiana State University Health Science Center Shreveport, Shreveport, LA

Oral Poster II Liver B Moderator: Adam Yopp

OP-B6.01 COMPREHENSIVE DNA METHYLATION ANALYSIS OF HEPATOCELLULAR CARCINOMAD. J. Weisenberger1, T. Hinoue1, L. Petrovic1, C. Romero1, L. S. Sher1; 1University Of Southern CA, Los Angeles, CA

OP-B6.02 SUCCESSFUL SURGICAL MANAGEMENT OF SUBACUTE BUDD-CHIARI SYNDROMEA. Mejia2, J. Jay1, R. Dickerman1, P. Mantry2; 1Methodist Dallas Medical Center, Dallas, TX; 2The Liver Institute At Methodist Dallas, Dallas, TX

OP-B6.03 CLINICAL EXPERIENCE WITH A 3-D IMAGE-GUIDANCE SYSTEM IN LAPAROSCOPIC LIVER RADIOFREQUENCY ABLATIONC. W. Hammill1, M. A. Cassera1, L. W. Clements2, R. F. Wolf1, P. D. Hansen1; 1Liver And Pancreas Surgery Program, Portland, OR; 2Pathfinder Therapeutics, Inc., Nashville, TN

OP-B6.04 ROUTINE AND SEAMLESS 3D LIVER LESION TARGETING FOR LAPAROSCOPIC ABLATION: ONE STEP CLOSERK. A. Simo1, D. Sindram1, I. H. McKillop1, S. Razzaque2, J. B. Martinie1, D. A. Iannitti1; 1Section Of Hepatobiliary And Pancreatic Surgery, Dept. General Surgery, Carolinas Medical Center, Charlotte, NC; 2InnerOptic Technology, Inc., Hillsborough, NC



Oral Poster II Liver B Continued

OP-B6.05 SPONTANEOUS REGRESSION OF HCC IS MOST OFTEN ASSOCIATED WITH TUMOR HYPOXIA OR SYSTEMIC INFLAMMATORY RESPONSEJ. I. Huz1, M. Melis1, U. Sarpel1; 1New York University School Of Medicine, New York, NY

OP-B6.06 RADIOFREQUENCY-ASSISTED LIVER RESECTIONM. Kerem1, O. Sakrak1, K. Dikmen1, H. Bostanci1; 1Gazi University, Medical Faculty, General Surgery Department, Ankara, ANKARA

OP-B6.07 METASTATIC HEMANGIOPERICYTOMA REQUIRING EX VIVO LIVER RESECTIONS. L. Bokshan1, M. B. Doyle1,2, W. C. Chapman1,2; 1Washington University School Of Medicine, Saint Louis, MO; 2Barnes-Jewish Hospital, Saint Louis, MO

OP-B6.08 MULTIDISCIPLINARY MANAGEMENT OF METASTATIC EWING SARCOMA TO LIVER: A FOCUS ON REGIONAL THERAPY AND REVIEW OF THE LITERATURES. G. De La Fuente1, A. Conley1, D. Reed1, J. Choi1, D. Letson1, R. J. Gonzalez1; 1H. Lee Moffitt Cancer Center, Tampa, FL

Oral Poster II Biliary/Other A Moderator: Michele Molinari

OP-B7.01 ANALYSIS OF 787 COMMON BILE DUCT EXPLORATIONS FROM THE NSQIP DATABASEJ. R. Gutnick1, A. E. Siperstein2; 1Cleveland Clinic, Cleveland, OH; 2Cleveland Clinic, Cleveland, OH

OP-B7.02 ENDEMIC GALLBLADDER CANCER: IS THERE A ROLE FOR PROPHYLACTIC CHOLECYSTECTOMY?E. R. Witkowski1, E. Ragulin-Coyne1, T. P. McDade1, L. W. Chen1, S. A. Shah1, J. F. Tseng1; 1Surgical Outcomes Analysis & Research (SOAR), University Of Massachusetts Medical School, Worcester, MA

OP-B7.03 PREOPERATIVE BILIARY DRAINAGE, REGARDLESS OF HOW ACHIEVED, DOES NOT IMPACT OUTCOMES FOLLOWING PANCREATICODUODENECTOMY FOR CANCERZ. P. Englert1, T. L. Fitzgerald1, M. B. Burruss1, E. E. Zervos1; 1East Carolina University, Greenville, NC

OP-B7.04 EVALUATION OF THE HJORTSJO CROOK SIGN IN THE DELINEATION OF THE RIGHT POSTERIOR BILE DUCT ANATOMY IN MIDDLE EASTERN PATIENTSH. M. Alghamdi1; 1University Of Dammam, Alkhobar, Eastern Provience; 2King Fahad Hospital Of The University, Alkhobar, Eastern Provience

OP-B7.05 TRANSECTION OF LEFT SEGMENTAL HEPATIC DUCTS DURING LAPAROSCOPIC CHOLECYSTECTOMYA. M. Williams1, R. Gedaly1, M. F. Daily1, M. B. Shah1, A. Dawkins2, J. C. Hundley1; 1University Of Kentucky, Lexington, KY; 2University Of Kentucky, Lexington, KY

OP-B7.06 MINIMALLY INVASIVE SURGEON IN HEPATOPANCREATOBILIARY SURGERY FELLOWSHIP: ONE ACADEMIC CENTERS MODELO. Hamed1, N. Gusani1, J. Kaifi1, E. Kimchi1, K. Staveley-O’Carroll1; 1Section Of Surgical Oncology, Department Of Surgery, Penn State College Of Medicine, Hershey PA, Hershey, PA

OP-B7.07 LONG TERM FOLLOW-UP AFTER PRIMARY EXCISION OF DUODENAL NEUROENDOCRINE TUMORS, A CASE SERIESJ. W. Rostas1, L. W. Thompson2; 1University Of South Alabama College Of Medicine, Mobile, AL; 2Cancer Surgery Of Mobile, P.C., Mobile, AL

OP-B7.08 DOES HEALTH INSURANCE PLAY A ROLE IN THE OUTCOME OF PEOPLE WITH HEPATOBILIARY CANCER?P. V. Cherian1, D. J. Christian2; 1University Of Arizona UMC South, Tucson, AZ 2Saint Francis Medical Center, Trenton, NJ


SATURDAY6:00 – 7:00 pm AHPBA Business Meeting

Room: Ocean Tower II C

6:15 - 8:15 pM parallel Dinner SyMpoSia

Multidisciplinary Management of hepatocellular Carcinoma (No CME Credits Provided)Rooms: Ocean Tower II A/BModerator: Todd W. BauerFaculty: Nael Saad, Diane Reidy, William Chapman

Topics include:•Indications and Timing of Theraspheres and

TACE for HCC•Sorafenib and other Targeted Agents for HCC•Surgical Management of HCC•Panel Discussion: Integrating Therapies in

Patients with HCC

Supported by an educational grant from Onyx Pharmaceuticals & Bayer HealthCare

The Best of 2012 ahpBa/SSo/SSaT Consensus Conference on the Multidisciplinary Treatment of Colorectal Cancer liver Metastases (No CME Credits Provided)Room: Ocean Tower 1 A/BPanelists: Jean-Nicolas Vauthey, Eddie K. Abdalla, Thomas A. Aloia, Roderich E. Schwarz

Supported by an educational grant from Genentech

Selection for Hepatic Resection – Felipe Jose Fernandez Coimbra

Locoregional Surgical and Interventional Therapies for Advanced CLM – Yun Shin Chun

Systemic Cytotoxic and Biologic Therapies – Bryan M. Clary

eVening on your own


SUNDAY7:00 am - 11:00 am Registration Desk

Location: Ocean Tower 1 Foyer

7:00 am - 9:00 am Continental BreakfastRoom: Ocean Tower 1 Foyer

7:30 - 8:30 aM parallel CoMpeTiTiVe ViDeoS

Liver Room: Ocean Tower I BModerators: Nick O’Rourke and Allan Tsung

Pancreatic/Biliary Room: Ocean Tower I AModerators: Tom Clancy and Andrew Gumbs

Competitive Video I - LiverRoom: Ocean Tower I BModerators: Nicholas O’Rourke and Allan Tsung

CV-1.01 ISOLATED TOTAL CAUDATE LOBECTOMY UNDER EXTRAHEPATIC GLISSONEAN APPROACHA. Sugioka1, Y. Kato1, T. Tokoro1, Y. Tanahashi1, J. Yoshida1, T. Kagawa1, C. Takeura1; 1Department of Surgery, Fujita Health University, Toyoake, Aichi Japan

CV-1.02 RIGHT TRISECTIONECTOMY PLUS CAUDATE LOBE RESECTION FOR HILAR CHOLANGIOCARCINOMA IN A PATIENT WITH GBWR<0,8L. McCormack1, J. Kerman Cabo1, A. Sanchez Ruiz1, P. Mendez1, N. Goldaracena1; 1Liver Surgery & Trasplantation Unit, Hospital Aleman Of Buenos Aires, Argentina

CV-1.03 LAPAROSCOPIC LEFT HEMIHEPATECTOMY FOR LEFT-SIDED HILAR CHOLANGIOCARCINOMA WITH BILIARY RECONSTRUCTION BY THE HYBRID METHODM. A. Machado1, M. Mochizuki1, R. C. Surjan1, F. F. Makdissi1; 1University Of Sao Paulo, Sao Paulo

CV-1.04 EX-VIVO RIGHT TRISECTIONECTOMY WITH CAVAL RESECTIONF. A. Alvarez1, J. I. Iniesta1, E. Sieling1, J. Pekolj1, E. De Santibañes1; 1General Surgery Service-HPB Surgery Section, Hospital Italiano De Buenos Aires, Ciudad Autonoma De Buenos Aires

Competitive Video II - Pancreas/BiliaryRoom: Ocean Tower I AModerators: Tom Clancy and Andrew Gumbs

CV-2.01 LAPAROSCOPIC EXCISION OF TYPE IV A CHOLEDOCHAL CYST INCLUDING LEFT HEPATECTOMYJ. Chavez1, E. Lin1, J. Sarmiento1; 1Emory University, Atlanta, GA

CV-2.02 ROBOT-ASSISTED RESECTION OF CHOLEDOCHOCELE IN AN ADULT WITH HEPATICOJEJUNOSTOMY AND INTRACORPOREAL ROUX-EN-Y ANASTOMOSISS. G. Carpenter1, T. A. De Masters1, E. P. Castle2, D. C. Mulligan1; 1Mayo Clinic Arizona, Division Of Transplant Surgery, Phoenix, AZ; 2May Clinic Arizona, Department Of Urology, Phoenix, AZ

CV-2.03 POST NECROTIC PANCREATIC PSEUDOCYST. LAPAROSCOPIC TECHNIQUES.O. Mazza1, L. Yazde1, R. Sanchez Claria1, J. Salceda1, J. Pekolj1; 1Hospital Italiano De Buenos Aires. General Surgery Service And HPB Surgery Section, Buenos Aires, Argentina

CV-2.04 THE STANDARDIZATION OF LAPARO-ENDOSCOPIC SINGLE SITE (LESS) CHOLECYSTECTOMYS. B. Ross1, H. Paul2, K. Luberice2, F. Co2, E. Choung2, A. Rosemurgy2; 1University Of South Florida, Tampa, FL; 2Tampa General Medical Group, Tampa, FL


8:30 – 10:30 aM parallel SeSSionS

Oral Pancreas II Abstracts, with Embedded Invited VideoRoom: Ocean Tower I AModerator: Tercio de Campos and Dave Bentrem

New Patient Care Guideline Session: Perioperative VTE Prophylaxis in Liver SurgeryOcean Tower 1 BModerators: Thomas Aloia & Giles Toogood

Oral Quick Shot I Abstracts, with Embedded Invited VideoRoom: Ocean Tower I CModerators: Emily Winslow & Pedro Barberan

Video: Laparoscopic Klatskin Tumor Resection – Juan Sarmiento

Maximal VTE Prophylaxis In Liver Surgery – Al Hemming

Tailored Approach to VTE Prophylaxis in Liver Surgery – Bryan Clary

Minimal VTE Prophylaxis In Liver Surgery – Luis Augusto Carneiro D’Albuquerque

Expert Medical Perspective on VTE Prophylaxis in Liver Surgery – William Geerts

Long Oral II-D - Pancreas IIRoom: Ocean Tower I AModerators: David Bentrem and Tercio De Campos

O2-D.01 IMPACT OF PREOPERATIVE THERAPY ON PATTERNS OF RECURRENCE IN PANCREATIC CANCERP. Papavasiliou1, J. P. Hoffman1, J. C. Watson1, Y. S. Chun1; 1Fox Chase Cancer Center, Philadelphia, PADiscussant: Peter Allen

O2-D.02 NATURAL HISTORY OF ASYMPTOMATIC PANCREATIC CYSTIC NEOPLASMSG. Morris-Stiff1, G. A. Falk1, S. Chalikonda1, R. M. Walsh1; 1Department Of General Surgery, Section Of Surgical Oncology/HPB, Cleveland, OHDiscussant: Nicholas Zyromski

O2-D.03 COMPUTED TOMOGRAPHY ENHANCEMENT AND PATIENT CHARACTERISTICS AS PREDICTORS OF COMPLICATIONS AFTER PANCREATICODUODENECTOMYJ. C. McAuliffe1, K. A. Parks1, S. McNeal1, D. E. Morgan1, J. D. Christein1; 1University Of Alabama At Birmingham, Birmingham, ALDiscussant: David Adams

O2-D.04 PALLIATIVE SURGERY IN UNRESECTABLE PERIAMPULLARY CANCER: DOES OPERATIVE BYPASS DECREASE POSTOPERATIVE PROCEDURES AND HOSPITAL DAYS?J. M. Lyons1, A. M. Karkar1, C. Correa-Gallego1, M. I. D’Angelica1, R. P. DeMatteo1, T. P. Kingham1, W. R. Jarnagin1, M. F. Brennan1, P. J. Allen1; 1Memorial Sloan-Kettering Cancer Center, New York, NYDiscussant: Richard Schulick

Invited Video: Laparoscopic Enucleation of Tumors Arising in the Head-Neck of the Pancreas – Laureano Fernandez Cruz

O2-D.05 CHEST CT AND POSITRON EMISSION TOMOGRAPHY (PET) IN PATIENTS WITH PANCREATIC ADENOCARCINOMA: ADDED INFORMATION OR JUST ADDED COST?S. G. Pappas1, K. Chrisitans1, P. Tolat1, A. Lal2, L. McElroy1, A. Mautz1, T. C. Gamblin1, K. Turaga1, T. Susan1, R. Paul1, B. A. Erickson1, D. Foley1, D. Evans1; 1Medical College Of Wisconsin, Milwaukee, WI; 2Columbia Saint Mary’s Hospital, Milwaukee, WIDiscussant: Jennifer Tseng

SUNDAY


8:30 – 10:30 aM parallel SeSSionS Continued

Long Oral II-D - Pancreas II Room: Ocean Tower I A

O2-D.06 P53 MUTATIONAL ANALYSIS IS A BETTER PREDICTOR OF PROGNOSIS THAN HISTOLOGY IN PANCREATIC IPMN.J. A. Nicholson1, L. Yan1, R. Sutton1, S. Harrison1, F. Campbell2, J. P. Neoptolemos1, W. Greenhalf1; 1NIHR Pancreas Biomedical Research Unit, Liverpool, MERSEYSIDE; 2Deapartment Of Histopathology, Liverpool, MerseysideDiscussant: Christopher Wolfgang

O2-D.07 IS PREOPERATIVE IMAGING PREDICTIVE OF OUTCOME IN PATIENTS UNDERGOING TOTAL PANCREATECTOMY WITH ISLET AUTOTRANSPLANTATION FOR CHRONIC PANCREATITIS?K. A. Morgan1, J. Romagnuolo1, S. M. Owczarski1, D. B. Adams1; 1Medical University Of South Carolina, Charleston, SCDiscussant: Syed Ahmad

Mini Oral I (Quick Shot I) Room: Ocean Tower I CModerators: Emily Winslow and Jose Pedro Barberan

MO-A.01 DECREASING TRENDS IN SURGERY FOR PANCREATIC CANCER: A 21-YEAR POPULATION-BASED ANALYSISD. M. Hari1, A. M. Leung1, C. G. Chiu1, S. L. Stern1, A. J. Bilchik1,2,3; 1John Wayne Cancer Institute, Santa Monica, CA; 2David Geffen School Of Medicine At University Of CA, Los Angeles, CA; 3CA Oncology Research Institute, Los Angeles, CA

MO-A.02 RECURRENCE, SALVAGE, AND SURVIVAL AFTER TWO-STAGE HEPATECTOMY FOR COLORECTAL LIVER METASTASESK. Cardona1, D. Donataccio1, N. Kemeny1, T. P. Kingham1, P. J. Allen1, R. P. DeMatteo1, Y. Fong1, W. R. Jarnagin1, M. I. D’Angelica1; 1Memorial Sloan-Kettering Cancer Center, New York, NY

MO-A.03 RESIDUAL DISEASE (RD) PREDICTS OUTCOME AFTER DEFINITIVE RESECTION FOR INCIDENTAL GALLBLADDER CANCER (IGBC)J. M. Butte1, M. Gonen2, M. I. DAngelica1, P. J. Allen1, T. P. Kingham1, Y. Fong1, R. P. DeMatteo1, W. R. Jarnagin1; 1Department Of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY USA, New York, NY; 2Department Epidemiology And Biostatistics, Memorial Sloan-Kettering Cancer Cent, New York, NY

MO-A.04 CHOLEDOCHODUODENOSTOMY IS AN EXCELLENT ALTERNATIVE TO ROUX Y CHOLEDOCHOJEJUNOSTOMYJ. G. Peacock1, J. K. Heimbach2, S. L. Nyberg2, C. B. Rosen2; 1Mayo Medical School, Rochester, MN; 2Mayo Clinic And Mayo Clinic College Of Medicine, Rochester, MN

MO-A.05 CONVERSION TO COMPLETE SURGICAL TREATMENT USING HEPATIC ARTERY INFUSIONAL CHEMOTHERAPY IN PATIENTS WITH UNRESECTABLE LIVER METASTASES FROM COLORECTAL CANCERJ. B. Ammori1, N. E. Kemeny2, Y. Fong2, A. Cercek2, R. P. Dematteo2, P. J. Allen2, P. B. Paty2, W. R. Jarnagin2, M. I. D’Angelica2; 1University Hospitals Case Medical Center, Cleveland, OH; 2Memorial Sloan-Kettering Cancer Center, New York, NY

MO-A.06 PANCREATIC ADENOCARCINOMAS ARISING ON THE BACKGROUND OF PANCREATIC CYSTIC DISEASE HAVE A BETTER OUTCOME THAN POOR OUTCOMEG. Morris-Stiff1, G. A. Falk1, S. Chalikonda1, R. M. Walsh1; 1Department Of General Surgery, Section Of Surgical Oncology/HPB, Cleveland, OH

MO-A.07 DO INDETERMINATE PULMONARY NODULES REPRESENT LUNG METASTASES IN PATIENTS UNDERGOING LIVER RESECTION FOR HEPATOBILIARY MALIGNANCIES?S. Downs-Canner1, R. Bahar1, S. K. Reddy1, J. S. Cardinal1, J. W. Marsh1, D. A. Geller1, A. Tsung1; 1University Of Pittsburgh Medical Center, Liver Cancer Center, Pittsburgh, PA

SUNDAY

Continued next page



Mini Oral I (Quick Shot I) Room: Ocean Tower I C

MO-A.08 EVALUATION OF SERUM MESOTHELIN AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER FOR PANCREATIC ADENOCARCINOMAZ. W. Kendrick1, M. A. Firpo1,4, C. L. Scaife1,4, D. G. Adler2,4, K. M. Boucher3,4, S. J. Mulvihill1,4; 1Department Of Surgery, Salt Lake City, UT; 2Division Of Gastroenterology, Salt Lake City, UT; 3Department Of Oncological Sciences, Salt Lake City, UT; 4Huntsman Cancer Institute, Salt Lake City, UT

MO-A.09 ISOLATED HEPATIC PERFUSION (IHP) FOR ISOLATED UNRESECTABLE COLORECTAL LIVER METASTASES (CRCLM)D. Magge1, H. J. Zeh2, D. Lenzner1, J. Young2, J. Pingpank2, H. Choudry2, M. Holtzman2, D. Bartlett2, A. Zureikat2; 1University Of Pittsburgh Medical Center, Pittsburgh, PA; 2UPMC Surgical Oncology, Pittsburgh, PA

MO-A.10 HOSPITAL READMISSION AFTER PANCREATICODUODENECTOMY: AN EMERGING QUALITY METRICZ. J. Kastenberg1, J. M. Morton1, B. C. Visser1, J. A. Norton1, G. A. Poultsides1; 1Department Of Surgery, Stanford University Medical Center, Stanford, CA

Invited Video: Laparoscopic Klatskin Tumor Resection – Juan Sarmiento

MO-A.11 LIVER-SPLEEN ATTENUATION RATIO PREDICTS CHEMOTHERAPY-ASSOCIATED STEATOHEPATITIS IN MULTIDISCIPLINARY TREATMENT OF COLO-RECTAL LIVER METASTASESS. Cecchini1,2, E. Alfaro1, M. Ligorio1, D. Sahani1, D. L. Berger1, K. K. Tanabe1, L. Y. Gregory1, C. R. Ferrone1; 1Massachusetts General Hospital, Boston, MA; 2Parma University, Parma, Italy

MO-A.12 A SIMPLE ALGORITHM OF EARLY DRAIN REMOVAL AFTER PANCREATICODUODENECTOMYV. Menon1, A. Annamalai1, V. Puri1, H. Kotler1, N. N. Nissen1; 1Cedars-Sinai Medical Center, Los Angeles, CA

MO-A.13 IMPROVED SURVIVAL IN AFRICAN AMERICAN MALES WITH INTRAHEPATIC CHOLANGIOCARCINOMA LARGELY DUE TO INCREASED OPERATIVE TREATMENTD. Sindram1, K. A. Simo1, J. B. Martinie1, D. A. Iannitti1; 1Section Of Hepatobiliary And Pancreatic Surgery, Dept. General Surgery, Carolinas Medical Center, Charlotte, NC

MO-A.14 LOW BASELINE LEAN BODY MASS NEGATIVELY PREDICTS COMPLETION OF NEOADJUVANT THERAPY AMONG PATIENTS WITH RESECTABLE AND BORDERLINE RESECTABLE PANCREATIC CANCERE. A. Asare1, P. Knechtges1, D. Green1, Q. Ziang1, T. C. Gamblin1, K. Turaga1, S. G. Pappas1, K. K. Christians1, E. J. Quebbeman1, D. B. Evans1, S. Tsai1; 1Medical College Of Wisconsin, Milwaukee, WI

MO-A.15 INCREASING AGE AND DECREASED FUNCTIONAL STATUS ARE INDEPENDENT PREDICTORS OF POSTOPERATIVE COMPLICATIONS AND DEATH FOLLOWING HEPATIC RESECTIONSS. G. De La Fuente1, D. Shibata1, B. M. Clary2, K. M. Bennett2, J. E. Scarborough2; 1H. Lee Moffitt Cancer Center, Tampa, FL; 2Duke University Medical Center, Durham, NC

MO-A.16 QUALITY OF LIFE ASSESSMENT OF LOCAL PANCREATIC HEAD RESECTION FOR CHRONIC PANCREATITIST. D. Fischer1, D. S. Gutman1, E. A. Warner1, J. G. Trevino1, S. J. Hughes1, K. E. Behrns1; 1Department Of Surgery, Gainesville, FL

MO-A.17 IMPACT ON QUALITY OF LIFE AFTER BILE DUCT INJURY REPAIR: A PROSPECTIVE STUDY COMPARING SCORES BEFORE AND A YEAR AFTER SURGERYB. Franssen1, I. Dominguez1, F. Ramirez-Del Val1, M. Mercado1; 1Department Of Surgery, Instituto Nacional De La Nutricion Mexico City, Mexico

MO-A.18 MULTIVISCERAL PANCREATIC RESECTIONS: ARE THEY WORTH THE RISK?A. Siripong1, M. Chung1; 1Grand Rapids Medical Education Partners/Michigan State Univ General Surgery Residency Program, Grand Rapids, MI

SUNDAY



Mini Oral I (Quick Shot I) Room: Ocean Tower I C

MO-A.19 SURGICAL TREATMENT FOR PRIMARY AND LOCALLY ADVANCED/METASTATIC SOFT-TISSUE SARCOMA INVOLVING THE PANCREAS AND LIVERM. Sabbaghian1, G. Rosen1, H. Pachter1, J. Raccuia1; 1New York University School Of Medicine, New York, NY

MO-A.20 INDICATIONS, TECHNIQUE AND OUTCOMES FOR CENTRAL PANCREATECTOMY. AN UPDATED EXPERIENCE.C. Correa-Gallego1, J. LaFemina1, M. D’Angelica1, R. DeMatteo1, P. Kingham1, Y. Fong1, W. R. Jarnagin1, P. J. Allen1; 1Memorial Sloan-Kettering Cancer Center, New York, NY

10:30 aM – 12:30 pM parallel SeSSionS

Symposium – Emerging Therapeutic Approaches to Primary and Metastatic Neuroendocrine TumorsRoom: Ocean Tower I AModerators: Tim Pawlik & Lee Thompson

Long Oral Liver II Abstracts, with Embedded Invited VideoRoom: Ocean Tower I BModerators: Michael Jacobs & Eric Kamichi

Video: Caval Resection/Ex Vivo Perfusion – Ian McGilvray

Oral Quick Shot II Abstracts, with Embedded Invited VideoRoom: Ocean Tower I CModerators: Julie Stein & Andre de Moricz

Video: Laparoscopic Living Donor Resection (Adult to Child) – Nicolas Jarufe Cassis

Surgical Resection of Primary Neuroendocrine Tumors of the Pancreas and Gastrointestinal Tract – Jeff Norton

Surgical Management of Metastatic Neuroendocrine Tumors to the Liver – Tim Pawlik

Intra-Arterial Regional Therapy of Metastatic Neuroendocrine Disease to the Liver: Where Do We Stand? – Jean-Francois H. Geschwind

Systemic Treatment of Metastatic Neuroendocrine Tumors to the Liver: Dawn of a New Era? – Diane L. Reidy

10:30 aM – 12:30 pM parallel SeSSionS

Long Oral II-E - Liver II Room: Ocean Tower I B Moderators: Mike Jacobs and Eric Kimchi

O2-E.01 EVALUATION OF STAPLER HEPATECTOMY DURING LAPAROSCOPIC LIVER RESECTIONJ. F. Buell1, B. Gayet1, H. Han1, G. Wakabayashi1, K. Kim1, G. Belli1, R. Cannon1, H. Keneko1, C. Gamblin1, G. Brock1, I. Dagher1; 1International Consensus Group For Laparoscopic Liver Surgery, And Tulane University, New Orleans, LADiscussant: Michael D’Angelica

SUNDAY

Continued next page


10:30 aM – 12:30 pM parallel SeSSionS Continued

Long Oral II-E - Liver II Room: Ocean Tower I B Continued

O2-E.02 SAFETY AND EARLY EFFICACY OF IRREVERSIBLE ELECTROPORATION FOR HEPATIC TUMORS IN PROXIMITY TO VITAL STRUCTURESR. M. Cannon1, D. Hays2, W. Goodwin2, S. Bagla3, G. McLennan4, G. Narayanan5, R. C. Martin1; 1University Of Louisville, Department Of Surgery, Division Of Surgical Oncology, Louisville, KY; 2Baptist Health, Little Rock, AK; 3INOVA, Springfield, VA; 4Cleveland Clinic, Cleveland, OH; 5University Of Miami, Miami, FLDiscussant: Michael Choti

O2-E.03 SIMULTANEOUS COLORECTAL AND HEPATIC PROCEDURES FOR COLORECTAL CANCER: INCREASED MORBIDITY BUT EQUIVALENT MORTALITY TO COLORECTAL OR HEPATIC PROCEDURES ALONE - OUTCOMES FROM THE NATIONAL SURGICAL QUALITY IMPROVEMENT PROJECT (NSQIP)O. Hamed1, J. T. Kaifi1, E. T. Kimchi1, K. F. Staveley-O’Carroll1, N. J. Gusani1; 1Surgical Oncology - Penn State College Of Medicine, Hershey, PADiscussant: Luiz Carneiro D’Albuquerque

Invited Video Presentation: Caval Resection Ex Vivo Perfusion – Ian McGilvray

O2-E.04 ROBOTIC VERSUS LAPAROSCOPIC LEFT LATERAL SECTIONECTOMY: COMPARISON OF CLINICAL AND ECONOMIC OUTCOMESV. Packiam1, J. Marsh2, J. Cardinal2, S. Reddy2, M. Saul2, D. Geller2, D. Bartlett2, A. Tsung2; 1University Of Pittsburgh School Of Medicine, Pittsburgh, PA; 2University Of Pittsburgh Medical Center, Pittsburgh, PADiscussant: Branden Visser

O2-E.05 LONG TERM SURVIVAL IN PATIENTS WITH METASTATIC GASTROINTESTINAL STROMAL TUMORS TO THE LIVER AND OTHER LOCATIONSS. G. De La Fuente1, J. L. Deneve1, C. Parsons1, A. Conly1, R. J. Gonzalez1; 1H. Lee Moffitt Cancer Center, Tampa, FLDiscussant: Chandrakanth Are

O2-E.06 COMPLETE RESPONSE TO TACE FOR HCC DOES NOT MEAN CUREJ. C. Henry1, L. Malhotra1, M. Bloomston1, C. R. Schmidt1; 1Ohio State University Department Of Surgery, Columbus, OHDiscussant: Michele Molinari

O2-E.07 SURGEON SPECIALIZATION AND UTILIZATION AFTER HEPATECTOMY IN ACADEMIC MEDICAL CENTERSJ. J. Shaw1, C. W. Macomber1, H. P. Santry1, J. F. Tseng1, S. A. Shah1; 1University Of Massachusetts Medical School, Worcester, MADiscussant: John Martinie

Oral Quick Shot IIRoom: Ocean Tower I CModerators: Julie Stein and Andre de Moricz

MO-B.01 INCIDENCE AND IMPLICATIONS OF IMPAIRED GLYCEMIC CONTROL FOLLOWING DISTAL PANCREATECTOMYM. Rogers1, G. Morris-Stiff1, G. A. Falk1, S. Chalikonda1, L. Yerian2, R. M. Walsh1; 1Department Of General Surgery, Section Of Surgical Oncology/HPB, Cleveland, OH; 2Department Of Histopathology, Cleveland, OH

MO-B.02 RESECTION OF MULTI-SITE METASTASES FROM COLORECTAL CANCER: FEASIBILITY AND INTERIM RESULTS OF A MULTI-CENTRE PROSPECTIVE PHASE II STUDYA. C. Wei1, N. G. Coburn2, C. Moulton1, S. P. Cleary1, C. Law2, P. D. Greig1, S. Gallinger1; 1Toronto General Hospital, University Health Network, Toronto, ON; 2Odette Cancer Center Sunnybrook Hospital, Toronto, ON

SUNDAY



Oral Quick Shot II Room: Ocean Tower I C Continued

MO-B.03 CONFOCAL MICROSCOPY IN COMBINATION WITH OBLIQUE INCIDENCE DIFFUSE REFLECTANCE SPECTROSCOPY FOR THE CONFIRMATION OF TUMOR FREE SURGICAL MARGINS IN PANCREATIC CANCERA. Amini1, B. Banerjee1, A. Garcia-Uribe2,3, J. Zou2, L. Wang3, A. Rouse1, A. Gmitro1, T. Jie1, R. Gruessner1, E. Ong1; 1University Of Arizona, Tucson, AZ; 2Texas A&M University, College Station, TX; 3Washington University In St. Louis, St. Louis, MO

MO-B.04 COAGULOPATHY FOLLOWING LIVER RESECTION: IS IT OVERDIAGNOSED AND OVERTREATED?J. S. Barton1, G. M. Riha1, J. A. Differding1, S. J. Underwood1, J. L. Curren1, B. C. Sheppard1, R. F. Pommier1, S. L. Orloff1, M. A. Schreiber1, K. G. Billingsley1; 1Oregon Health And Science University, Portland, OR

MO-B.05 META-ANALYSIS OF PHASE 3 RANDOMIZED TRIALS ASSESSING THE ROLE OF MOLECULAR TARGETED THERAPIES IN THE MANAGEMENT OF ADVANCED PANCREATIC CANCERK. M. Eltawil1, M. Molinari1; 1Depatment Of Surgery, Dalhousie University, Halifax, Nova Scotia

MO-B.06 LAPAROSCOPIC VS. OPEN LEFT LATERAL SECTIONECTOMY AND RIGHT HEPATECTOMY: A COST-EFFECTIVENESS ANALYSIS FOR MINOR AND MAJOR HEPATECTOMYM. Abu Hilal1, S. M. Syed2, R. Wiltshire1, F. DiFabio1, N. J. Pearce1, J. N. Primrose1; 1Southampton University Hospital Trust, Southampton, HAMPSHIRE; 2Synergy Medical Healthcare Alliance, Saginaw, MI

MO-B.07 CULTURE-DIRECTED TREATMENT OF BACTERIOBILIA AND BILIARY CANDIDIASIS AFTER WHIPPLE DECREASES POST-OPERATIVE INFECTIONSC. H. Evans1,4, S. E. Hodges1,4, C. J. Balentine1,2,3, W. E. Fisher1,4; 1Baylor College Of Medicine, Houston, TX; 2Houston VA HSR&D Center Of Excellence, Houston, TX; 3Michael E. DeBakey VA MC, Houston, TX; 4Elkins Pancreas Center, Houston, TX

MO-B.08 TREATMENT OF RECURRENT HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION; ARE WE MAKING PROGRESS?A. Annamalai1, V. Menon1, V. Puri1, C. Bresee1, B. Boland1, A. S. Klein1, J. Fair1, S. D. Colquhoun1, N. N. Nissen1; 1Cedars-Sinai Medical Center, Los Angeles, CA

MO-B.09 YIELD OF CLINICAL AND RADIOGRAPHIC SURVEILLANCE IN PATIENTS WITH RESECTED PANCREATIC ADENOCARCINOMA FOLLOWING MULTIMODALITY THERAPYC. D. Tzeng1, J. B. Fleming1, J. E. Lee1, X. Wang1, P. W. Pisters1, J. N. Vauthey1, G. Varadhachary1, R. A. Wolff1, C. H. Crane1, M. H. Katz1; 1The University Of Texas MD Anderson Cancer Center, Houston, TX

MO-B.10 LAPAROSCOPIC CHOLECYSTECTOMY IN PATIENTS WITH ASCITES AND/OR ESOPHAGEAL VARICES; PREDICTORS OF MORTALITYS. W. CHO1, M. Cassera1, N. Bhayani1, P. Newell1, C. Hammill1, R. Wolf1, P. Hansen1; 1Liver And Pancreas Surgery Program, Providence Portland Medical Center, Portland, OR

Invited Video Presentation: Laparoscopic Living Donor Resection (Adult to Child) – Nicolas Jarufe Cassis

MO-B.11 SURGICAL RESECTION IN HEPATOCELLULAR CARCINOMA PATIENTS WITH MINIMAL BACKGROUND FIBROSIS; A STRATEGY IN THE ERA OF ORGAN SHORTAGER. T. Groeschl1, S. G. Pappas1, K. K. Christians1, S. Tsai1, E. J. Quebbeman1, T. C. Gamblin1, K. K. Turaga1; 1Medical College Of Wisconsin, Milwaukee, WI

MO-B.12 INHIBITOR OF DIFFERENTIATION-1 (ID1) EXPRESSION CORRELATES WITH SRC ACTIVATION AND TUMOR DIFFERENTIATION IN HUMAN PANCREATIC CANCER SPECIMENSJ. G. Trevino1, B. A. Centeno2, S. N. Hochwald1, S. J. Hughes1, K. E. Behrns1, S. P. Chellappan2; 1University of Florida-Gainesville, Gainesville, FL; 2H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

SUNDAY

Continued next page



Oral Quick Shot II Room: Ocean Tower I C Continued

MO-B.13 ROLE OF LYSOPHOSPHATIDIC ACID IN THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA.N. J. Skill1, J. Wu1, M. A. Maluccio1; 1Indiana University, Indianapolis, IN

MO-B.14 NATIONAL TRENDS IN PANCREATICODUODENAL TRAUMA: INTERVENTIONS AND OUTCOMES.E. Ragulin-Coyne1, E. R. Witkowski1, Z. Chau1, S. Ng1, D. Wemple1, S. A. Shah1, H. Santry1, J. F. Tseng1; 1Surgical Analysis & Outcomes (SOAR), University Of Massachusetts, Worcester, MA

MO-B.15 RESECTION OF RENAL CELL CARCINOMA METASTATIC TO THE LIVER: A DUAL-CENTER ANALYSISY. Hatzaras1, C. Pulitano2, L. Aldrighetti2, R. Schulick1, M. Choti1, B. Edil1, K. Hirose1, C. Wolfgang1, T. M. Pawlik1; 1Johns Hopkins Hospital, Baltimore, MD; 2Liver Unit, Scientific Institute San Raffaele, Milan, Italy

MO-B.16 TECHNICAL REFINEMENT OF ROBOT-ASSISTED PANCREATICODUODENECTOMY: IMPROVING OUTCOMES AT A SINGLE INSTITUTION.M. Daouadi1, A. H. Zureikat1, M. S. Zenati2, S. Chalikonda3, D. L. Bartlett1, H. J. Zeh1, A. J. Moser1; 1UPMC Cancer Pavilon, Pittsburgh, PA; 2UPMC Presbyterian, Pittsburgh, PA; 3Cleveland Clinic Main Campus, Cleveland, OH

MO-B.17 UP FRONT HEPATIC RESECTION FOR METASTATIC COLORECTAL CANCER RESULTS IN FAVORABLE LONG-TERM SURVIVALS. Nanji1, S. Cleary2, P. Ryan3, M. Guindi3, S. Selvarajah2, P. Greig2, I. McGilvary2, B. Taylor2, A. Wei2, C. Moulton2, S. Gallinger2; 1Queen’s University, Department Of Surgery, Kingston, Ontario; 2University Health Network, University Of Toronto, Department Of Surgery, Toronto, Ontario; 3University Of Toronto, Department Of Pathology, Toronto, Ontario

MO-B.18 DISTAL SPLENORENAL AND MESOCAVAL SHUNTING AT THE TIME OF PANCREATECTOMY FOR CANCERK. K. Christians1, K. Riggle1, R. Keim2, S. Pappas1, P. Ritch1, B. A. Erickson1, P. P. Tolat1, D. B. Evans1; 1Medical College Of Wisconsin, Milwaukee, WI; 2Albany Liver And Pancreas Surgery, Albany, NY

MO-B.19 PREDICTORS OF SURVIVAL IN GALLBLADDER CANCER: A REVIEW OF 90 PATIENTS SUBMITTED TO SURGERY WITH CURATIVE INTENT.D. Cavallucci1, A. Fox1, S. Cleary1; 1University Health Network, Toronto General Hospital, Toronto, ON

MO-B.20 THE SIX-DAY WHIPPLE PATHWAYD. M. Walters1, A. L. Strong1, E. W. Good1, R. B. Adams1, T. W. Bauer1; 1The University Of Virginia, Department Of Surgery, Charlottesville, VA

12:30 pm Closing Address by the New President Room: Ocean Tower I A President William Jarnagin

Be sure to get a ticket as you enter the room. For those loyal to this last session, one lucky person will win a complimentary registration to the 2013 AHPBA Meeting!

SUNDAY


exHibit Hall and Poster floor Plan

ENTRANCE

F&B

BAR

POMPEII BALLROOM

AHPBA 2012


bootH #15angioDynaMiCS14 Plaza DriveLatham, NY 12110518-795-1814Fax: 518-795-1401www.angiodynamics.com

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for oncology, surgery, peripheral vascular disease and vascular access. AngioDynamics’ diverse product lines include market-leading radiofrequency ablation and surgical resection devices and the NanoKnife® System.

bootHs #21 & 22BioCoMpaTiBleSChapman House, Farnham Business ParkWeydon LaneFarnham, Surrey, UK GU9 8QL44 0 1252 732753Fax: 44 0 1252 732703www.biocompatibles.com

Biocompatibles, with its heritage of leadership and innovation in interventional oncology, is now a BTG International group company. We are investing in product development and clinical trials to deliver on a shared vision of excellence in interventional medicine.

bootH #23Bk MeDiCal8 Centennial DrivePeabody, MA 01960724-586-2799Fax: 509-272-0452www.bkmed.com

BK Medical’s Flex Focus 700 premium ultrasound system is tailored for the surgical suite. It is small, lightweight, supporting a comprehensive range of sterilizable transducers, and can be battery powered.

bootH #14CariS life SCienCeS6655 N. MacArthur Blvd.Irving, Texas 75039214-716-4057800-879-8292Fax: 214-596-2280www.carislifesciences.com

The Caris Target Now™ evidence-based molecular profiling service matches tumor-specific molecular data with biomaker/drug associations in clinical literature, uncovering therapies more likely to work for each patient. Visit www.carislifesciences.com

bootH #1ChirhoClin, inC.4000 Blackburn Lane, Ste. 270Burtonsville, MD 20866301-476-8388Fax: 301-476-9529www.chirhoclin.com

ChiRhoClin, Inc. is the manufacturer of ChiRhoStim® (Human Secretin for injection). Our mission is to develop orphan drug products that diagnose gastrointestinal diseases. ChiRhoStim® is approved for Pancreatic Function Testing, ERCP’s, and Gastrinoma Testing. Finally, you can improve your MRCP images with Secretin-enhanced MRCP or use EUS combined with Secretin to perform a EUS- Pancreatic Function Test.

bootHs #16 & 17CoViDien5920 Longbow DriveBoulder, CO 80303303-581-6997Fax: 303-581-6898www.covidien.com

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence.

Exhibitors


bootH #6eDDa TeChnology5 Independence WayPrinceton, NJ 08540609-919-9889 x 109Fax: 609-919-9779www.edda-tech.com

EDDA Technology provides intuitive solutions in computer assisted radiology and surgery. IQQA®-Liver allows real-time interactive, quantitative, automated 3D evaluation of liver, liver lobes/segments, lesions, and vessels, plus virtual planning of resection.

bootH #13elSeVier inC.1600 John F. Kennedy Blvd, Suite 1800Philadelphia, PA 19103215-239-3493Fax: 215-239-3494www.elsevier.com

ELSEVIER, dedicated to being your integral partner in delivering exceptional healthcare. Trust ELSEVIER to offer superior resources that expand your knowledge, foster communication, build insights, enable individual and collective advancement in the healthcare field. ELSEVIER proudly publishes Mosby, Saunders, and Churchill Livingstone titles. ELSEVIER. Building Insights. Breaking Boundaries

bootH #9erBe uSa2225 Northwest ParkwayMarietta, GA 30067770-955-4400Fax: 770-995-2577www.erbe-usa.com

ERBEJET® 2, is a unique water jet dissector that uses an extremely thin laminar jet, rotated in a helical fashion, to force softer, more water-soluble tissue to separate, sparing fibrin-rich structures. This optimizes the preservation of vessels, ducts, and nerves. The ERBEJET® 2 can be used in both open and laparoscopic procedures.

bootHs #18, 19 & 20eThiCon enDo-Surgery4545 Creek RoadCincinnati, OH 45242513-8334135Fax: 513-337-1525www.ees.com

Ethicon Endo-Surgery, a Johnson & Johnson company, develops and markets advanced medical devices for minimally invasive and open surgical procedures, focusing on procedure-enabling devices for the interventional diagnosis and treatment of conditions in general and bariatric surgery, as well as gastrointestinal health, gynecology and surgical oncology. More information can be found at www.ethiconendo.com.

bootH #11hiTaChi aloka MeDiCal10 Fairfield BlvdWallingford, CT 06492203-269-5088 Ext.228Fax: 203-269-6075www.hitachi-aloka.com

Hitachi Aloka Medical’s commitment to ultrasound for surgeons offers a wide range of consoles and specifically designed transducers to meet the needs of every surgeon.

bootHs #26inTegra311 Enterprise DrivePlainsboro, NJ 08536609-275-0500800-997-4868Fax: 609-799-3297www.integralife.com

Integra LifeSciences, a world leader in medical devices, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers a vast portfolio of implants, devices, instruments and systems used in neurosurgery and neuro critical care.

Exhibitors


bootHs #4 & 5MeDTroniC aDVanCeD energy180 International DrivePortsmouth, NH 03801603-842-6253www.medtronic.com

Medtronic’s advanced energy products provide haemostatic sealing of soft tissue and bone by delivering proprietary Transcollation® technology Aquamantys® bipolar sealers and monopolar hand pieces have treated more than 700,000 patients worldwide.

bootHs #2 & 3MiCroSuliS MeDiCal lTDUnits 1-2 Parklands Business Park, DenmeadPortsmouth, Hampshire, P07 6XP UK0044 (23) 92 240011Fax: 0044 (23) 92 240051www.microsulis.com

A specialist medical device company with market leading, game changing solutions in microwave ablation. Our products deliver significant technological and clinical advances to physicians and patients in minimally invasive, soft tissue ablation.

bootH #25neuwaVe MeDiCal, inC.3529 Anderson StreetMadison, WI 53704608-512-1511Fax: 608-512-1509www.neuwavemedical.com

Powerful microwave energy in the hands of the surgeon. The Certus 140 System maximizes synchronized power deliver to soft tissue in laparoscopic/open procedures providing rapid coagulation resulting in tissue hemostasis.

bootH #24onyX pharMaCeuTiCalS & Bayer healThCare249 East Grand AvenueSan Francisco, CA 94115650-266-2356Fax: 650-266-0356www.onyx-pharm.com

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals are committed to cancer research and treatment options. We continually apply our experience, knowledge and passion to develop new cancer therapies.

bootH #10paThfinDer TherapeuTiCS, inC.2969 Armory Drive, Suite 100ANashville, TN 37204874-420-2339Fax: 615-783-0554

www.pathsurg.com

Pathfinder has developed Explorer, the first FDA-cleared navigation system for liver surgery, which enables real-time tracking of resection and ablation devices relative to preoperative imaging, as well as intraoperative ultrasound.

Exhibitors


bootH #7reDpaTh inTegraTeD paThology2515 Liberty AvenuePittsburgh, PA 15222412-224-6100Fax: 412-224-6115www.redpathip.com

RedPath Integrated Pathology, Inc. is a genomics-based diagnostic laboratory providing specialized testing for difficult-to-diagnose cancer cases. RedPath’s patented PathFinderTG platform integrates enhanced molecular-based analyses of cytology fluids and microdissected specimens with traditional pathology leading to early and more definitive cancer diagnosis, thus improving clinical management and patient outcomes.

bootH #8SuperSoniC iMagine, inC.1920 E. Hallandale Beach Blvd. Suite 905Hallandale, FL 3300954-399-9374Fax: 954-457-2448www.supersonicimagine.fr

SuperSonic Imagine is a multinational medical imaging company that manufactures the Aixplorer. Using a method of imaging called ShearWave™ Elastography; The Aixplorer can measure and visualize tissue elasticity in real time.

bootH #12ThoMpSon SurgiCal inSTruMenTS10170 E Cherry Bend Rd.Traverse City, MI 49684231-922-5178Fax: 231-922-0174www.thompsonsurgical.com

Thompson Surgical is the original manufacturer of table-mounted retractors. In use for over thirty years, the Thompson Retractor is the only mechanical retractor to offer one frame for all exposure needs, multi-planed retraction, and unlimited customization. Stop by our booth so you can see our latest innovations that will provide you uncompromised exposure.

Exhibitors


Disclosures

Syed ahmadEthicon Endosurgery

Consultant/AdvisorConsulting Fee

John allendorfCovidien


kenneth ChavinBridge To Life


Christos galanopoulosIntuitive Surgical

Consultant/AdvisorSpeaker/Lecturer/Meeting participantIndependent contractorOther activities National Robotic ProctorConsulting Fee

william geertsLeo Pharma

Consultant/AdvisorMember on advisory committees or review panelsConsulting Fee

PfizerSpeaker/Lecturer/Meeting participantHonoraria

Sanofi AventisSpeaker/Lecturer/Meeting participantHonorariaOther financial benefit Program Support Though The Hospital

Bayer HealthcareSpeaker/Lecturer/Meeting participantMember on advisory committees or review panelsHonorariaConsulting FeeOther financial benefit Program Support

Michael houseSalient Surgical Technologies


CryoLife, Inc.Consultant/AdvisorConsulting Fee

David iannittiCovidien

Speaker/Lecturer/Meeting participantHonoraria

EthiconSpeaker/Lecturer/Meeting participantConsulting Fee

robert MartinAngiodynamics


arthur MoserCelgene

InvestigatorOther financial benefit Research Grant

GenentechInvestigatorOther financial benefit Research Grant

NewLink GeneticsInvestigatorOther financial benefit Research Grant

Diane reidy-lagunesNovartis And Pfizer

Member on advisory committees or review panelsHonoraria

alex rosemurgyCovidien , Olympus


nael SaadSirtex

Other activities ProctorConsulting Fee

Juan SarmientoCovidien


C. Max SchmidtRedpath Inc

Consultant/AdvisorSpeaker/Lecturer/Meeting participantHonorariaConsulting Fee

roderich SchwarzNovartis


Shimul ShahCovidien


kevin watkinsAngioDynamics

Member on advisory committees or review panelsHonoraria

S weberCovidien

Other activities Member DSMBConsulting Fee

sPeakers, moderators, discussantsThe following Speakers/Moderators/Discussants provided information to be disclosed.


AHPBA 2012

angel e. alsinaBayer, Novartis

Bayer-Speaking, Consulting Novartis- SpeakingRole - Consultant/AdvisorRole - Speaker/Lecturer/Meeting participantReceived - Consulting Fee

george BerciKarl Storz Endoscopy

Dr. Berci Receives An Unrestricted Grant From Karl Storz Endosocopy And Has Received HonorariaRole - Consultant/AdvisorRole - Speaker/Lecturer/Meeting participantReceived - Consulting FeeReceived - Honoraria

andrea CercekSynta And Lorus

Research FundingRole - InvestigatorResearch Funding

edward ChoungLaparoscopic Fellowship Council

SalaryFellowshipReceived - Salary

logan w. ClementsPathfinder Therapeutics, IncMedical Device Company

Role - EmploymentReceived - SalaryReceived - RoyaltyReceived - Intellectual property rightsReceived - Ownership interest

John p. leoneBehring, Novartis

Grant Research And Advisor PositionRole - Consultant/AdvisorReceived - Consulting Fee

guy w. neffSalix, Vertex, Merck, Geneteck, Salix

Speaking, Advisory, Grant ResearchRole - Consultant/AdvisorRole - Speaker/Lecturer/Meeting participantReceived - Consulting Fee

Sharif razzaqueInnerOptic Technology, Inc.

Development Of Visualization Software Improve Image Guided Interventions By Reducing Procedure Time And Errors, Resulting In Better Patient Outcomes.Role - EmploymentReceived - Salary

alexander rosemurgyCovidien, Olympus

SpeakerRole - Speaker/Lecturer/Meeting participantReceived - Honoraria

Juan SarmientoCovidien

Speaker HonorariaRole - Speaker/Lecturer/Meeting participantReceived - Honoraria

Selwyn M. VickersMinneamrita Therapeutics, LLC

Minnelide, A Derivative Of Triptolide Designed By The University Of Minnesota, Has Been Licensed To The Above Company For Undertaking Of Clinical Trials.Role - OwnerReceived - RoyaltyReceived - Ownership interest

Daniel J. weisenbergerZymo Research Corporation

DJ Weisenberger serves as a consultant for Zymo Research, a company which sells and distributes kits for epigenetic and genetic research. This work was not sponsored by Zymo Research Corporation, nor does Zymo Research have an interest in the outcome of this research.Role - Consultant/AdvisorReceived - Consulting Fee

emmanuel e. zervosCare Fusion Inc.

Ad Hoc ConsultantRole - Consultant/AdvisorReceived - Consulting Fee

abstract autHorsThe following Abstract Authors provided information to be disclosed.

All other Speakers/Moderators/Discussants and Abstract Authors do not have any relevant financial relationship to disclose with their participation at the 2012 AHPBA Annual Meeting.


AHPBA 2013

ANNUAL MEETINGFEBRUARY 20 – 24, 2013

AMERICAS HEPATO-PANCREATO- BILIARY ASSOCIATION

EDEN ROC RENAISSANCE, MIAMI BEACH, FLORIDA

iHPba / kennetH Warren foundation donorsWe are proud to recognize our donors and would like to thank all of the Organizations and Individual Supporters whose continued generosity allows us to promote the research on diseases of the liver, pancreas and biliary tract.

leadersMarkus BüchlerJ.L. CameronCarlos Fernandez-del CastilloO. James GardenDirk Joan GoumaH. Scott HeltonJoan E. KolliganJoseph W.Y. LauYuji NimuraHenry A. PittJames ToouliSally Warren

benefactorsMichael D’AngelicaGlenn SteeleJean-Nicolas VautheyJohn Windsor

sPonsorsClem ImrieYoshifumi KawaradaSatoshi KondoAtushi Sugioka

friends

international life circleThomas WarrenWiley Blackwell, Inc.

researcH steWards circle C. Wright Pinson

Eduardo AkaishiMohammed AlsaghierTaku AokiGerard AranhaTakehide AsanoChristoph AuschTelesforo BacchellaClaudio BassiShantanu BasuJacques BelghitiGuilio BelliNeil Anthony BerrySyryabhan BhaleraoAndrew BiankinGiulio BelliGiovanni Antonio BonillaChristoph BroelschMarkus BuechlerIain CameronMatteo CesconEddy Hok Chin ChanJohn W. ChenStanley ChenZhibin ChengDaniel CherquiChol-Kyoon ChoRoland Montenegro CostaRaul CutaitEduardo de SantibañesMichael D’AngelicaHoracio D’AgostinoBobby DasariMark DeakinCornelis DejongElijah Dixon

Paul Michael DolanMarcelo EnneJonathan FawcettEvangelos FelekourasCarlos Fernandez-Del CastilloCraig FischerCarlos Florez-ZorillaYiliam FundoraEldar M. GadzijevSteven GallingerDieter Jose GarciaKleanthis GiannoulisJean-Francios GigotGeorgios Glantzounis Mehmet HaberalEllen HagopianHo-seong HanUlrich HoptArild HornThomas HowardThomas HughPalepu JagannathTimoleon KakavoulisSanteev KanoriaBasil P. KekisChen-Guo KerWolfram Trudo KnoefelValery KubyshkinNobuaki KurauchiPaul LadaRoberto LauroMickael LesurtelRichard LetourneauKam Fung Leung

Jun LiMichael Ka Wah LiMarcel MachadoSameer MihrshahiPaulo MiraKohji MiyazakiMichele MolinariFrank G. MoodyMariano MoroGareth Morris-StiffJorge Antonio Mosquera Satvinder MudanAkimasa NakaoLeslie NathansonJohn P NeoptolemosOvergaard NielsonYuji NimuraGregory NolanPeter David NottleShinji OsadaKarl-Joseph PaquetMaris PavarsZbigniew PuchalskiStefano PuleoGuntars PupelisRenyi QinSadasivan RamalingamAlvarao Riart Robert SammartanoWayne H. SchwesingerMarkus SelznerNorbert SenningerYan-Shen ShanHarjit SinghRoss C. Smith

Dinananth SonarKarl SondenaaDavid StellMichael StephenCheng-hsi SuMiguel Angel Suarez MunozAtsushi SugiokaMounib TaclaShin TakasakiSumihito TamuraMasao TanakaPavel TarazovHirtaka TashiroJorge H. Tobar de LeonGuido TorzilliEvangelos C. TsimoyiannisAjay K. UpadhyayAtsushi UrakamiThomas van GulikTjarda van HeekDionisios VrochidesToshifumi WakaiAndrew WarshawJ. Anthony WilliamsThomas WilsonJohn Albert WindsorErrawan WiradisuriaCheng-Chung WuEuripedes YettmisKeisuke YoshidaKrzysztof Zieniewicz

AHPBA 2013

ANNUAL MEETINGFEBRUARY 20 – 24, 2013

AMERICAS HEPATO-PANCREATO- BILIARY ASSOCIATION

EDEN ROC RENAISSANCE, MIAMI BEACH, FLORIDA

americas hepato–pancreato–biliary association - AHPBA...12th Aul eetig 1 AHPBA 2012...

Documents

Transcript of americas hepato–pancreato–biliary association - AHPBA...12th Aul eetig 1 AHPBA 2012...